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 ABSTRACT 
 
 
 During an immune response, T cell activation is mirrored by a dramatic metabolic 
shift from oxidative phosphorylation to glycolysis. The upregulation of glycolysis allows 
the cell to generate the molecules needed to rapidly proliferate and to synthesize effector 
molecules. The resolution of the T cell response is characterized by equally fast death of 
most effector T cells. The remaining T cells shift back to oxidative phosphorylation, 
allowing the cell to survive as a memory T cell. The upregulation of glycolysis and 
proliferation during the effector phase is paralleled by an increased sensitivity to T cell 
receptor restimulation-induced cell death (RICD). Whereas cellular metabolism and cell 
death are important in the proper function and response of T cells, it is not clear how 
metabolism regulates susceptibility to cell death, nor whether T cell proliferation and 
contraction are directly connected. The work presented in this dissertation provides a 
mechanistic link between T cell proliferation and contraction by demonstrating the 
regulation of caspase-3 activity by the metabolic state of T cells.  
 
 In effector T cells, the cytokine interleukin (IL)-2 mediates the upregulation of 
glycolysis, while IL-15 induces oxidative phosphorylation and a memory-like state. IL-2 
is known to sensitize T cells to RICD, while IL-15 reduces RICD and increases survival. 
This results from the ability of IL-2 and glycolysis to increase caspase-3 activity, whereas 
IL-15 induces the opposite phenotype. Activation of caspase-3 during glycolysis is 
mediated through clustering in lipid rafts in the plasma membrane. IL-15 is shown to 
inactivate caspase-3 through the posttranslational modification of protein 
glutathionylation, which is mediated by ROS generation in the mitochondria as a by-
product of oxidative phosphorylation. 
 
 We further observe that glycolysis parallels the reduced activity of the electron 
transport chain and oxidative phosphorylation, further increasing caspase-3 activity. This 
is mediated by the decreased expression of electron transport chain complexes and an 
increase in expression of the negative regulator of complex I, methylation-controlled J 
protein (MCJ). IL-15 promotes reduced expression of MCJ by its methylation. Similar to 
IL-15-cultured T cells, MCJ-deficient T cells manifest reduced glycolysis, caspase-3 
activity, and RICD. Collectively, these findings demonstrate an adaptation that links 
metabolism to both cell proliferation and cell death to safeguard that proliferating cells do 
not escape regulation that could result in autoimmune disease or lymphomas. 
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW 
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1.1 The Immune System 
 The immune system is a network of proteins, cells, and tissues that protects the 
host from infections by bacteria, fungi, viruses, and parasites. Defense is achieved 
through the ability to recognize non-self from self. To do this, the immune system utilizes 
many different cells that are specialized in recognizing and responding to self and non-
self molecules. To maintain both speed and breadth of response to infections, the immune 
system contains two different branches that evolved at different times, the innate immune 
system that is found even in insects, and the adaptive immune system found only in 
vertebrates (Yatim and Lakkis, 2015). 
1.1.1 Innate immune system 
 The innate immune system acts to generate a quick protection from pathogens. It 
takes the strategy of having a limited number of non-polymorphic receptors that 
recognize a limited number of motifs from microorganisms. The co-evolution of these 
receptors and their ligands provides high affinity and hence a rapid response (Martin, 
2014).  
 The complement system represents a group of proteins that cleave in a very 
precise order to induce inflammation and assist in the attack of microbial pathogens 
(Tomar and De, 2014). The proteins of the complement system work in three different 
pathways: the classical pathway, the lectin pathway, and the alternative pathway. These 
pathways all converge at the activation of the C3 convertase but are initiated by different 
means (Walport, 2001). The classical pathway is typically activated by antibodies bound 
to the surface of the pathogen. This leads to the binding of the C1 complex, which 
activates the C3 convertase (Walport, 2001). The lectin pathway is activated by either the 
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collectins mannose-binding lectin (MBL) or CL-K1, or the ficollins, which bind to 
carbohydrates on the surface of the pathogen and activate the MBL-associate serine 
proteases (MASPs). The MASPs then activate the C3 convertase (Kjaer et al., 2013). The 
alternative pathway is spontaneously activated in the serum through constant hydrolysis 
of the complement protein C3 (Roumenina et al., 2011). Upon binding to self surfaces, 
the pathway is inactivated by the prevention of C3 convertase formation. When 
hydrolyzed C3 binds to a pathogen, more complement proteins are deposited on the 
surface of the pathogen, and theC3 convertase becomes activated (Roumenina et al., 
2011). Once the C3 convertase is activated, complement proteins are deposited onto the 
pathogen that result in opsonization and phagocytosis, or the formation of a membrane-
attack complex which forms a pore and kills the pathogen (Walport, 2001). 
 The cells of the innate immune system are varied and act to attack pathogens as 
well as to activate the adaptive immune system. Innate immune cells recognize 
components of pathogens called pathogen-associated molecular patterns (PAMPs) via 
intracellular and surface receptors known as pattern recognition receptors (PRRs) 
(Martin, 2014). Upon recognition, signaling through PRRs lead to the activation of the 
innate immune cells and the production of inflammatory cytokines (Martin, 2014). 
PAMPs can be a number of different antigens from pathogens, ranging from DNA to 
fragments of bacterial flagella. PRRs include Toll-like receptors, NLRP proteins of the 
inflammasome, the RNA-sensing RIG-I pathway, and DNA-sensing cGAS/STING 
pathway (Cai et al., 2014; Janeway and Medzhitov, 2002; Kell and Gale, 2015; Martin, 
2014). The cells that express PRRs include granulocytes (basophils, eosinophils, and 
neutrophils), natural killer (NK) cells, dendritic cells (DCs), macrophages, and mast cells 
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(Janeway and Medzhitov, 2002). Macrophages and DCs are able to phagocytose 
pathogens, degrade their proteins, and present peptide fragments of them on MHC 
molecules to T cells in the adaptive immune system (Janeway and Medzhitov, 2002; 
Yatim and Lakkis, 2015). 
1.1.2 Adaptive Immune System 
 The adaptive immune system generates a wide array of T cell receptors (TCR) 
and B cell receptors (immunoglobulin) through random gene rearrangements (Tomar and 
De, 2014; Yatim and Lakkis, 2015). As a result, receptors of the adaptive immune system 
are highly polymorphic, manifest low affinity for their ligands, but provide great breadth 
of repertoire (Tomar and De, 2014). Consequently, the adaptive immune response is 
slower, but provide breadth and memory. B cells express a B cell receptor 
immunoglobulin that recognizes the three-dimensional structure of antigens. As B cells 
develop, the immunoglobulin gene undergoes a series of recombination events of its 
Variable (V), Diversity (D), and Joining (J) regions (termed V(D)J recombination) that 
allows for each B cell receptor to recognize a unique antigen (Roth, 2014). V(D)J 
recombination allows for a limited number of V, D, and J regions of DNA to be 
recombined into a large number of different immunoglobulins (Roth, 2014; Tomar and 
De, 2014; Yatim and Lakkis, 2015).This process of immunoglobulin gene recombination 
allows for B cells to respond to a much broader array of antigens compared to PRRs of 
the innate immune system. Once the B cell receptor interacts with its cognate antigen, the 
B cell becomes activated and begins proliferating and producing antibodies that 
recognize their antigenic epitope. During proliferation, B cell antibodies will undergo 
somatic hypermutation, a process through which the variable region of the antibody gene 
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is randomly mutated resulting a higher affinity antibody (Di Noia and Neuberger, 2007; 
Tomar and De, 2014). 
T cells express a T cell receptor (TCR) that also undergoes V(D)J recombination, 
though not somatic hypermutation, allowing T cells to recognize a similarly large array of 
antigens (Roth, 2014). The difference is that the TCR recognizes antigen complexed with 
self-major histocompatibility complex (MHC), or self-MHC-like, molecules on APCs 
(Malissen et al., 2014). Activated T cells perform a variety of functions, depending on the 
subset of T cell that is activated. The major T cell subsets are discussed further in the next 
section. 
 Following expansion in response to antigenic activation during an immune 
response, most T cells and B cells die, but a few survive to become memory cells. 
(Quintin et al., 2014; Sun et al., 2014). Immune memory allows for the immune system to 
respond quickly and with more intensity to a secondary infection. 
1.2 T cells 
 T cells, which express a T cell receptor (TCR), include αβ T cells, γδ T cells, 
natural killer T (NKT) cells, and mucosa-associated invariant T (MAIT) cells. 
Conventional αβ T cells are restricted to recognizing peptide antigens presented in 
complex with MHC I or MHC II. NKT cells, MAIT cells, and γδ T cells, vary in the 
types of antigens recognized by their limited repertoire of TCRs and are considered to 
function between the innate and adaptive immune system (Sun et al., 2014). NKT cells, 
which express an invariant TCR (Vα14-Jα18 α-chain in mice and Vα24-Jα18 α-chain in 
humans; known as Type I NKT cells) or a non-invariant TCR (known as Type II NKT 
cells) are restricted to interacting with lipid antigens presented on the MHC I-like 
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molecule CD1d (Kumar et al., 2017; Macho-Fernandez and Brigl, 2015; Trottein and 
Paget, 2018). MAIT cells express an invariant TCR (Vα19-Jα33 α-chain in mice and 
Vα7.2-Jα33 α-chain in humans) and are restricted to non-peptide small-molecule antigens 
presented on the MHC class I-like molecule MR1 (Trottein and Paget, 2018; Xiao and 
Cai, 2017). Putative antigens that γδ T cells have been found to recognize include 
antigens associated with MHC I-like molecules, as well as antigens not associated with 
MHC molecules. These putative antigens vary from peptides to lipids to proteins (Born et 
al., 2013; Champagne, 2011). 
 αβ T cells, henceforth called T cells, can be split into two distinct subsets based 
on the expression of the coreceptors CD4 or CD8. The TCR recognizes peptide antigen 
bound to the MHC in mice, or human leukocyte antigen (HLA) in humans on the surface 
of APCs (Wieczorek et al., 2017). There are two classes of MHC, class I and class II 
(Rock et al., 2016). MHC class I (HLA-A, -B, and -C in humans) binds small intrinsic 
peptides (about 8-10 amino acids in length) is expressed ubiquitously among cell types 
(Rock et al., 2016; Wieczorek et al., 2017). MHC class II (HLA-DR, -DP, -DQ in 
humans) binds to peptides (about 13-25 amino acids in length) from exogenous antigens 
that have been phagocytosed and processed within an APC (Rock et al., 2016; Wieczorek 
et al., 2017). The coreceptor (CD4 or CD8) expressed on the surface of the T cell 
determines which MHC the T cell will recognize; CD4 recognizes determinants on MHC 
class II and CD8 recognizes determinant on MHC class I (Rock et al., 2016). 
1.2.1 T cell development 
 T cells begin as hematopoietic stem cells generated in the bone marrow. These 
stem cells enter the thymus as thymic seeding progenitor cells. In the thymus, the 
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progenitor cells will undergo successive developmental steps during the CD4-CD8- 
double-negative (DN) stage, which can be divided into four phases based on the 
expression of CD25 and CD44: DN1, CD25-CD44+; DN2, CD25+CD44+; DN3, 
CD25+CD44-; DN4, CD25-CD44- (Lucas et al., 2016). During the transition from DN2 to 
DN3, T cell receptor rearrangement begins and developing thymocytes commit to either 
γδ T cells or αβ T cells. Between DN2 and DN3, the γ, δ, and β chain genes undergo 
rearrangement (Carpenter and Bosselut, 2010). If the γ and δ chains of the TCR 
successfully rearrange before the β chain, the cell becomes a γδ T cell (Carpenter and 
Bosselut, 2010). If the β chain successfully rearranges first, then the cell becomes an αβ T 
cell and enters the DN3 stage (Rothenberg, 2011). A pre-α chain pairs with the β chain to 
create a surface pre-TCR, and the cell enters the DN4 stage (Rothenberg, 2011). In DN4, 
CD4 and CD8 are expressed to create a CD4+CD8+ double-positive (DP) cell. During this 
DP stage, the α-chain of the TCR rearranges and is expressed, creating a mature TCR. 
The TCR on DP cells then interacts with self-peptide:MHC complexes (Carpenter and 
Bosselut, 2010). DP cells that recognize self-peptide:MHC with low affinity are 
positively selected, whereas those manifesting high affinity undergo negative selection 
and cell death (Carpenter and Bosselut, 2010). During this time, either the CD4 or CD8 
coreceptor will be downregulated, creating a CD4 or CD8 single-positive (SP) T cell. 
Mature CD4+ or CD8+ T cells will then leave the thymus and enter the periphery (Koch 
and Radtke, 2011; Shah and Zuniga-Pflucker, 2014; Zuniga-Pflucker, 2004). 
1.2.2 CD4+ T cells 
 CD4+ T cells are known as helper T (Th) cells because they secrete cytokines that 
promote the effector function of other immune cells. CD4+ T cells can be divided into 
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different subsets depending on the transcription factor that the cell expresses. Each subset 
secretes a different combination of effector cytokines. Subsets are identified by those 
secreted cytokines and their specific transcription factor (Geginat et al., 2013).  Th1 cells 
express the transcription factor T-bet, which induces the expression of interferon-γ (INF-
γ), the signature cytokine produced by Th1 cells.  INF-γ promotes the production of 
immunoglobulin IgG2a, induces antiviral responses, and activates macrophages to help 
protect against microbial pathogens and tumors through upregulation of phagocytosis and 
antigen presentation (Finkelman et al., 1988; Männel and Falk, 1983; Schoenborn and 
Wilson, 2007; Szabo et al., 2000; U. Boehm et al., 1997). Th1 cells also produce IL-2, 
which promotes T cell activation and effector function (Geginat et al., 2013; Liao et al., 
2013). 
 Th2 cells express the transcription factor GATA-3, which induces the expression 
of IL-4 and IL-5 (Zheng and Flavell, 1997). IL-4 induces antibody class switching in B 
cells to IgE, while IL-5 induces the proliferation of B cells and eosinophils (Caza and 
Landas, 2015; Takatsu, 2011). 
 Th17 cells express the transcription factors RORγT and RORα (Yang et al., 
2008). These transcription factors upregulate the expression of IL-17 and IL-17F, which 
induce the expression of antimicrobial peptides and inflammatory cytokines and 
chemokines (Kolls and Lindén, 2004; Liang et al., 2006). Th17 cells have been 
implicated in the pathogenesis of autoimmune diseases such as the mouse model of 
multiple sclerosis, experimental autoimmune encephalomyelitis (Komiyama et al., 2006).  
 Regulatory T (Treg) cells are CD4+ T cells that express the transcription factor 
FoxP3 and suppress the immune response in part through production of the 
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immunosuppressive cytokine IL-10. As such, Tregs help to reduce the effector function 
of immune cells and maintain tolerance for the prevention of autoimmune disease (Caza 
and Landas, 2015; Geginat et al., 2013). 
 Since CD4+ T cells depend on cytokines to promote and maintain subset 
differentiation, it is also possible for CD4+ T cells to switch between subsets. This ability 
to switch subsets is called plasticity, and some subsets are more sensitive to it than others. 
Th2 cells can easily become Th1 cells if IL-4 is removed from the culture media, though 
this switch may not be as easy the further these cells are from their initial activation 
(Murphy et al., 1996). Tregs and Th17 cells show a similar degree of plasticity (Caza and 
Landas, 2015; Xu et al., 2007). 
1.2.3 CD8+ T cells 
 CD8+ T cells are an important defense against intracellular pathogens such as 
viruses and intracellular bacteria, as well as tumors. Like CD4+ T cells, there is evidence 
for the existence of CD8+ T cell subsets that produce a variety of cytokines when 
activated, and therefore perform many different functions, though these subsets are not as 
well understood as the CD4+ subsets (Mittrucker et al., 2014). The major CD8+ T cell 
subset, and the one that is best understood, is called a cytotoxic T lymphocyte (CTL). 
Once activated, CTLs will secrete proinflammatory cytokines INF-γ and tumor necrosis 
factor α (TNF-α), which increase both the innate and adaptive immune response. 
Activated CTLs will also induce death in cells that express their cognate antigen on MHC 
class I. After recognizing the antigen, CTLs release granules containing granzymes and 
perforin. Granzymes are serine proteases that enter the target cell through pores created 
by perforin. Once in the cell, the granzymes will cleave proteins and induce apoptosis. 
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CTLs also kill by surface expression of Fas-ligand. CTLs are able to combat intracellular 
pathogens by inducing death in the infected cell, preventing the replication and spread of 
the pathogen (Mittrucker et al., 2014; Tscharke et al., 2015). 
1.2.4 T cell activation 
 Naïve T cells need to be activated to perform their effector function. Activation 
occurs when the naïve T cell receives two signals; one from the TCR and another from 
the costimulatory receptor CD28. The TCR exists in a complex with other proteins, of 
which the CD3 molecules (CD3 γ, δ, ε, and ζ) are important for signaling (Borst et al., 
1984; Samelson et al., 1986). When the TCR and CD4 or CD8 bind to the peptide:MHC 
complex, the lymphocyte-specific protein tyrosine kinase (Lck) bound to CD4 or CD8 
will phosphorylate CD3. The protein ζ-associated protein of 70 kDa (Zap70) is recruited 
to the phosphorylated CD3ζ, which leads to the phosphorylation of linker for activation 
of T cells (LAT) (Chan et al., 1992; Zhang et al., 1998a). Once activated, LAT will 
transduce a number of signals that ultimately lead to the activation of transcription factors 
activator protein 1 (AP-1) and nuclear factor of activated T cells (NFAT) (Smith-Garvin 
et al., 2009). As the TCR and coreceptors are engaged with the peptide:MHC complex, 
CD28 will bind to CD80 or CD86 on the APC, which results in a phosphorylation 
cascade leading to the activation of nuclear factor kappa-light-chain-enhancer of 
activated B cells (NFκB). These transcription factors will upregulate the expression of 
genes needed for the cell to proliferate and perform its effector function (Malissen and 
Bongrand, 2015; Malissen et al., 2014). IL-2 is one of the genes expressed as a result of 
NFAT and AP-1 activation (Liao et al., 2013). IL-2 promotes T cell proliferation, effector 
function, and induces glycolysis (Friedmann et al., 1996; Liao et al., 2013; Lin et al., 
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2012). Not only is glycolysis induced late in T cell activation through IL-2 signaling, it is 
also induced within hours after TCR stimulation as a result of pyruvate dehydrogenase 
kinase 1 activation and reduction of pyruvate import into mitochondria (Menk et al., 
2018). 
1.2.4.1 Role of lipid rafts in T cell signaling and activation 
 Lipid rafts, also called membrane rafts, are cholesterol-rich microdomains found 
in cellular membranes. These rafts are typically considered to be small regions of 
membrane, ranging from 10 nm to 200 nm, which includes caveolae and caveolin-rich 
regions of the membrane (Anderson and Jacobson, 2002; Pike, 2006). Though the 
composition of rafts is heterogenous and difficult to define, they are typically enriched in 
sphingolipids and sterols. Being enriched with these components allows rafts to be 
conducive for protein-protein interactions, as well as protein-lipid interactions (Pike, 
2006). This allows the clustering of proteins, which can stabilize multi-protein 
interactions and promote the compartmentalization of cellular processes. Stabilization of 
the rafts can also occur through interactions between raft-associated proteins and the 
cytoskeleton (Pike, 2006). While rafts are typically small, they can be recruited and 
stabilized into larger membrane domains (Anderson and Jacobson, 2002; Pike, 2006). 
Among the signaling proteins that have been described as localizing to rafts in T cells are 
Lck, LAT, TCR, CD28, and CD3 complex (Varshney et al., 2016; Zumerle et al., 2017). 
Relevant to this dissertation is caspase-8 complexed to its activator, c-FLIP, which has 
been described in lipid rafts in activated T cells (Misra et al., 2007). 
 A specific lipid raft in T cells is the immunological synapse. The immune synapse 
is formed where the TCR interacts with the MHC-peptide complex on an antigen-
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presenting cell, inducing activation of the T cell (Huppa and Davis, 2003). Many 
different proteins are involved in this interaction and nearly all the T cell-relevant 
proteins are found within lipid rafts at the immune synapse. These include the TCR, CD3 
complex, Lck, LAT, and CD28 (Varshney et al., 2016; Zumerle et al., 2017). While some 
of these proteins (e.g. TCR and CD28) have transmembrane domains, others, such as Lck 
and LAT, are recruited to the cell membrane and lipid rafts by posttranslational addition 
of fatty acids; LAT can be palmitoylated, whereas Lck can be both acylated and 
myristoylated (Zhang et al., 1998b). While membrane rafts are important for T cell 
activation, their function in other aspects of T cell biology is poorly understood. 
1.3 Cytokines 
 Cytokines are small secreted immunomodulatory proteins that act in a paracrine 
or autocrine manner similar to hormones. Cytokines can be produced by many different 
cell types including immune cells, fibroblasts, and endothelial cells.  
 Various groups of cytokines have been identified based on similarities in function 
or binding to common receptors. The common cytokine-receptor gamma-chain (γc) 
family is very important in regulating the proliferation and survival of T cells. These 
cytokine receptors are all heterodimeric or heterotrimeric and contain the γc (also known 
as CD132) as one of the subunits. The γc cytokines include interleukin (IL)-2, IL-4, IL-7, 
IL-9, IL-15, and IL-21. Some of the γc cytokines are important in the differentiation and 
proliferation of effector T cells (IL-2, IL-4, IL-9, and IL-21), while others are important 
in the homeostasis and survival of memory and naïve T cells (IL-7 and IL-15) (Rochman 
et al., 2009). Two of these cytokines, IL-2 and IL-15, are unique because they are the γc 
cytokines with trimeric receptors. Those receptors contain the γc, the IL-2 receptor β (IL-
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2Rβ or CD122), and the IL-2 receptor α (IL-2Rα or CD25) or IL-15Rα, for respectively, 
IL-2 or IL-15 (Waldmann, 2002). Though they share a similar receptor, IL-2 and IL-15 
differ in their contributions to T cell survival. 
1.3.1 IL-2 signaling 
 IL-2 was originally identified as a growth factor for T cells, which remains one of 
the best understood roles of IL-2 (Morgan et al., 1976). Both CD4+ and CD8+ T cells 
produce IL-2, though CD4+ T cells produce IL-2 to a greater extent (Paliard et al., 1988). 
IL-2 binds to the trimeric IL-2R, whose expression increases following T cell activation 
(Cantrell and Smith, 1983). Binding to the IL-2R induces a signaling cascade through the 
JAK/STAT pathway (primarily through JAK1 and JAK3, and subsequently STAT5 and 
STAT3), the PI3K pathway, and the ERK pathway (Fig. 1.1) (Johnston et al., 1995; Ring 
et al., 2012; Waldmann, 2015). PI3K signaling leads to mTOR activation, and the 
upregulation of glycolysis (Liao et al., 2013; Ray et al., 2015; Spolski et al., 2018; van 
der Windt et al., 2012). Through the upregulation of glycolysis, IL-2 increases the 
synthetic capacity of the cell to allow rapid proliferation during an immune response 
(Ray et al., 2015). After induction of glycolysis, IL-2 is important for maintaining 
proliferation and function of effector CD8+ T cells, as well as many of the CD4+ T cell 
subsets. 
In addition to its role in T cell proliferation, IL-2 has a critical role in cell death. 
In effector T cells, IL-2 increases sensitivity to apoptosis by activation-induced cell death 
and Fas (CD95)-mediated death (Lenardo, 1991; Refaeli et al., 1998). In this regard, a 
striking and unanticipated finding was that mice deficient in CD25 accumulate T cells 
and develop autoimmune symptoms, further supporting the fact that IL-2 is important in 
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T cell death (Willerford et al., 1995). While it is clear that IL-2 has a role in both 
proliferation and cell death, the mechanism by which IL-2 increases sensitivity to death is 
not well understood. 
 
1.3.2 IL-15 signaling 
 Similar to IL-2, IL-15 binds to a trimeric receptor composed of both the γc and 
CD122 subunits, as well as IL-15Rα. IL-15 can bind to the IL-15R through cis-
presentation (when the IL-15Rα is on the cell receiving the signal) or through trans-
presentation (when IL-15 is bound to the IL-15Rα and presented by a neighboring cell) 
and can be produced by monocytes, dendritic cells, and fibroblasts (McInnes and Liew, 
Figure 1.1: Signaling through the IL-2 and IL-15 receptors 
15 
 
1998a; Waldmann, 2015). IL-15 binding initiates a signaling cascade similar to IL-2, 
activating JAK1 and JAK3, followed primarily by STAT5 (Ring et al., 2012; Rochman et 
al., 2009). Signaling through the IL-15 receptor also leads to PI3K and ERK signaling 
(Fig. 1.1) (Ring et al., 2012; Waldmann, 2015). Originally described as a proliferative 
cytokine for T cells, like IL-2, it was later shown that IL-15 also promotes survival in T 
cells by reducing restimulation-induced cell death, which is promoted by IL-2 (Burton et 
al., 1994; Grabstein et al., 1994; Marks-Konczalik et al., 2000). The increased survival 
promoted by IL-15 is related to an important function of the cytokine, homeostatic 
proliferation and maintenance of memory CD8+ T cells (Tan et al., 2002). Due to its 
ability to maintain T cell populations for extended periods of time, as well as activate NK 
cells, IL-15 can induce tissue damage when it is over expressed. This is apparent in the 
synovial tissue of patients with rheumatoid arthritis, where the synovium contains high 
levels of IL-15 and low levels of IL-2, which can lead to prolonged T cell expansion and 
survival, contributing to the tissue damage in rheumatoid joints (McInnes and Liew, 
1998b). 
 Due to the similarities in signaling with IL-2, there has been much interest in 
trying to understand the cause for the differences in phenotypes induced by IL-2 and IL-
15 signaling. It is thought that differences in receptor binding strength, tissue context, and 
activation state (in the context of T cells) all play a role in determining these differences 
(Castro et al., 2011; Ring et al., 2012; Waldmann, 2015). One difference of interest is in 
the susceptibility to cell death induced by IL-2 versus IL-15. Previous studies from our 
group have shown the decreased death in IL-15-cultured T cells to be due to inactivation 
of caspase-3 by the posttranslational modification S-nitrosylation of the critical cysteine 
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in the enzymatic pocket of caspase-3. (Saligrama et al., 2014). Additional studies have 
revealed a parallel between the increased T cell survival with IL-15 and its promotion of 
oxidative phosphorylation and fatty acid utilization (O'Sullivan et al., 2014; van der 
Windt et al., 2012). However, it is not known how, or if, the metabolic differences 
between IL-2-cultured and IL-15-cultured T cells directly influence sensitivity to cell 
death. 
1.4 Immunometabolism 
 Metabolism is the combination of anabolic and catabolic processes within the cell. 
The anabolic processes are those used to generate sugars, fats, amino acids, nucleotides, 
among other molecules that are necessary for maintenance of cell integrity and 
proliferation. Those necessary substrates that cannot be made through anabolic processes 
are transported into the cell from the environment. The catabolic processes are those that 
break down large molecules into smaller components, either to feed the anabolic 
processes or to generate energy.  
In most cells, glycolysis and oxidative phosphorylation are the major pathways 
used to generate ATP. Glucose is catabolized to pyruvate and then acetyl-CoA to fuel the 
tricarboxylic acid (TCA) cycle in the mitochondria. The energy-carrying products of 
glycolysis and the TCA cycle are NADH and FADH2, whose electrons fuel the electron 
transport chain (ETC). The ETC pumps protons across the inner membrane of the 
mitochondria to produce an energy potential. This energy potential is used by ATP 
synthase, or complex V of the ETC, to create ATP. Fatty acid oxidation also contributes 
to ATP generation through catabolism of fatty acids such as palmitate, which results in 
the production of NADH, FADH2, and acetyl-CoA to fuel the ETC. 
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In addition to its metabolism in generating ATP, glucose utilization can also be 
diverted into the pentose phosphate pathway to create intermediates needed for lipid, 
protein, and nucleotide synthesis. Glucose can also be stored to make glycogen in muscle 
cells, astrocytes, hepatocytes, and dendritic cells, which is then used to fuel the TCA 
cycle after being catabolized back to glucose (Roach et al., 2012; Thwe et al., 2017). 
When glucose is not fueling the TCA cycle, immune cells tend to use glutamine and fatty 
acids to maintain OXPHOS. 
Metabolism plays an important role in the function immune cells, and the 
metabolites used can dictate which function the cells have. Many techniques have been 
developed to determine the metabolic pathways used by cells. One of the most powerful 
tools is the use of heavy isotope-labeled metabolites in cell culture media, combined with 
mass spectrometry. Heavy isotope-labeled metabolites contain stable, heavy isotopes of 
carbon, nitrogen, and/or hydrogen that can be differentiated from their normal 
counterparts by mass spectrometry. When these labeled metabolites are added to the 
culture medium, the cells will incorporate those heavy atoms as they normally would, but 
now the atoms can be tracked. This allows for the identification of the metabolic 
pathways to which a cell will divert a given metabolite (Jang et al., 2018). Techniques 
such as this help to identify how cells are able to use different metabolites under different 
growth conditions. The following sections describe the major metabolic pathways of 
immunometabolism, and how those pathways dictate immune cell function, with an 
emphasis on T cells. 
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1.4.1 Glycolysis 
 Glycolysis is a catabolic process that converts one 6-carbon glucose molecule into 
two 3-carbon pyruvate molecules using 2 ATP molecules (Fig. 1.2). The process begins 
with the transport of glucose into the cell through one of fourteen glucose transporters. 
After entering the cell, glucose is rapidly phosphorylated by hexokinase, resulting in 
glucose-6-phosphate (G6P). This phosphorylation event uses the first ATP molecule. 
G6P is converted to fructose-6-phosphate by phosphoglucose isomerase. The second 
ATP is used by phosphofructokinase to convert F6P to fructose-1,6-bisphosphate 
(F1,6P). At this point, the six-carbon sugar F1,6P is converted into two three-carbon 
sugars by aldolase. This reaction creates one dihydroxyacetone phosphate (DHAP) and 
one glyceraldehyde-3-phosphate (GAP). DHAP is rapidly converted to GAP by triose 
phosphate isomerase. The three-carbon sugar GAP is further converted by 
glyceraldehyde-3-phosphate dehydrogenase into 1,3-bisphosphoglycerate (1,3-BPG), 
which is then converted to 3-phosphoglycerate (3-PG) by phosphoglycerate kinase, 
generating a molecule of ATP in the process. 3-PG is converted into 2-phsophoglycerate 
(2-PG) by phosphoglycerate mutase. Enolase converts 2-PG into phosphoenolpyruvate 
(PEP), which is finally used by pyruvate kinase to make pyruvate. Thus, one molecule of 
glucose results ultimately in two pyruvate molecules. 
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1.4.1.1 Importance of glycolysis in immune cells 
Glycolysis plays an important role in the activation and effector function of many 
immune cells. Dendritic cells undergo a glycolytic burst after activation by TLR antigens 
(Everts et al., 2014). T cells, NK cells, B cells, and macrophages all undergo a similar 
switch to glycolysis after activation (Caro-Maldonado et al., 2014; Hume et al., 1978; 
Rodriguez-Prados et al., 2010; Roos and Loos, 1973a). For T cells, glycolysis is 
maintained by effector CD8+ T cells, as well as Th1, Th2, and Th17 CD4+ T cells 
(Michalek et al., 2011; van der Windt et al., 2012). Whereas glycolysis does generate 
some ATP (a net yield of 2 ATP per glucose molecule), the reason for the increase in 
glucose catabolism with immune cell activation is thought to be primarily for the 
Figure 1.2: Steps of glycolysis 
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generation of metabolic intermediates needed to fuel the anabolic processes needed for 
rapid cell growth and effector function. 
 Many of the glycolytic intermediates are used in other metabolic pathways. G6P 
can be used in both glycogen synthesis and to fuel the pentose phosphate pathway. The 
primary non-glycolytic function for G6P is in the synthesis of nucleotide precursors and 
the reducing agent NADPH through the pentose phosphate pathway. G6P can also be 
converted to glycogen, a branched polymer of glucose. Glucose storage as glycogen is 
most well known in muscle and liver cells, though recent studies have shown glycogen 
metabolism to play an important role in dendritic cell and T cell biology (Ma et al., 2017; 
Thwe et al., 2017). Dendritic cells have been shown to generate and store glycogen, 
which is used to support effector functions such as cytokine production and antigen 
processing and presentation. Memory T cells have also been found to store glucose as 
glycogen, which is catabolized to G6P to fuel the pentose phosphate pathway. 
Amino acid metabolism is another major use of glucose, fed by 3-PG (serine 
biosynthesis), PEP (tryptophan biosynthesis), and pyruvate (alanine biosynthesis). 
Pyruvate, along with contributing to alanine metabolism, is converted into two important 
metabolites, lactate and acetyl-CoA. Pyruvate is converted into lactate by lactate 
dehydrogenase, which uses NADH as a cofactor. This replenishes NAD+, which can then 
be used as an electron acceptor in glycolysis and the TCA cycle. Generally, lactate is 
considered a byproduct of highly glycolytic cells. Recently, however, lactate has been 
shown to modulate CD8+ T cells function, causing the loss of cytolytic activity and 
migratory function (Haas et al., 2015). Macrophages are polarized toward an M2 
phenotype in high lactate environments (Pucino et al., 2017). Pyruvate is converted to 
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acetyl-CoA by pyruvate dehydrogenase. Acetyl-CoA is the base substrate for fatty acid 
synthesis and can be used to generate lipids and fatty acids for the cell. Acetyl-CoA is 
also one of the primary carbon donors for the TCA cycle. 
1.4.2 Tricarboxylic acid cycle 
 Also known as the Krebs cycle or the citric acid cycle, the tricarboxylic acid 
(TCA) cycle is the primary method used by cells to shuttle electron donors, NADH and 
FADH2, into the electron transport chain at, respectively, complexes I and II. This results 
in a net yield of 32 ATP, making the TCA cycle plus OXPHOS the major source of ATP 
in the cell.  
 The TCA cycle occurs in the matrix of the mitochondria (Fig. 1.3). Pyruvate is 
transported into mitochondria and converted into acetyl-CoA by pyruvate dehydrogenase. 
Acetyl-CoA can then enter the TCA cycle by reacting with oxaloacetate in a process 
catalyzed by citrate synthase. Acetyl-CoA is attached to oxaloacetate before the 
coenzyme A group is removed. The final product is citrate, which is then isomerized to 
isocitrate by aconitase. Isocitrate dehydrogenase decarboxylates isocitrate to create α-
ketoglutarate and a molecule of NADH. Another NADH molecule is generated as α-
ketoglutarate is converted to succinyl-CoA by α-ketoglutarate dehydrogenase. Succinyl-
CoA is converted to succinate by succinyl-CoA synthetase, creating succinate. Succinate 
is converted to fumarate by succinate dehydrogenase, an enzyme that is part of complex 
II of the electron transport chain. This reaction generates one molecule of FADH2, which 
is used by complex II to transfer electrons to the electron transport chain. Fumarase 
creates catalyzes the reaction of fumarate to malate, which is followed by the conversion 
of malate to oxaloacetate by malate dehydrogenase. This final step of the TCA cycle 
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generates a final molecule of NADH, and completes the cycle, allowing oxaloacetate to 
be regenerated to react with acetyl-CoA once more. Since two acetyl-CoA molecules are 
generated from one glucose molecule, the full catabolism of glucose results in 6 NADH 
molecules and 2 FADH2 molecules to be generated from the TCA cycle. 
 
1.4.2.1 Importance of the TCA cycle in immune cells 
 Carbons can enter and exit the TCA cycle at nearly every intermediate. In fact, 
immune cells that undergo a high amount of glucose utilization for proliferation need to 
fuel the TCA cycle with other metabolites, so the glycolytic intermediates can be used for 
biosynthetic purposes. Citrate is at the first major junction of the TCA cycle. After being 
generated by citrate synthase, citrate can exit the mitochondria and be converted back to 
acetyl-CoA, which can then be used for fatty acid synthesis to generate lipids. While it 
Figure 1.3: Steps of the tricarboxylic acid cycle 
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may seem wasteful for the cell to generate citrate from acetyl-CoA only to turn that 
citrate back into acetyl-CoA, cells that catabolize a lot of glucose can send those carbons 
to feed the TCA cycle and generate the lipids needed to support growth and proliferation. 
Fatty acids generated through this pathway can also be used to support the TCA cycle. 
Fatty acid synthesis supported by glycolysis is important in the differentiation of CD4+ T 
cells into either Th17 cells or Treg cells. Th17 cells are shifted toward a Treg phenotype 
when acetyl-CoA carboxylase 1 (ACC1), an enzyme involved in fatty acid synthesis, is 
inhibited. Tregs rely on the oxidation of externally derived fatty acids, further indicating 
the importance of fatty acid synthesis in Th17 development and function (Berod et al., 
2014a). 
Citrate and succinate also play important roles in inflammatory macrophages. 
When citrate accumulates in bone marrow-derived macrophages (BMDM) activated by 
LPS, it can be converted to itaconate, which was found to cause an accumulation of 
succinate by inhibiting succinate dehydrogenase (Lampropoulou et al., 2016). Reducing 
the production of itaconate led to an increase in succinate dehydrogenase activity, a 
decrease in succinate levels, and in increase HIF-1α and the production of inflammatory 
cytokines such as IL-1β and IL-18. An earlier study of succinate metabolism in 
macrophages had shown that after LPS stimulation, BMDM use γ-aminobutyric acid 
(GABA) to make succinate (Tannahill et al., 2013). Reducing succinate generated from 
GABA led to a reduction in HIF-1α and IL-1β production. Although a reduction in 
succinate led to two opposing results, the flow of carbons into the TCA cycle was 
different between studies and this may be more important than the levels of succinate in 
determining macrophage effector function. Together, these studies demonstrate that 
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citrate, succinate, and carbon flow through the TCA cycle are important factors in 
macrophage and T cell function. 
An additional notable metabolite is α-ketoglutarate, as it is the second major entry 
point into the TCA cycle for carbons in immune cells. Glutamine is known to be critically 
important for supporting immune cell function, and a large reason for that is because 
glutamine is converted to glutamate, which is then used to generate α-ketoglutarate as a 
fuel source for the TCA cycle.  
1.4.3 Glutaminolysis 
 Glutamine is an important amino acid, as it can be used to generate many 
different molecules. Glutamine is transported into the cell by a variety of transporters 
(ASCT2 is an important glutamine transporter on T cells) and can then be used to 
generate purines, pyrimidines, amino acids, or glutamate (Nakaya et al., 2014; Pochini et 
al., 2014). Carbons from glutamate can be incorporated into the TCA cycle through α-
ketoglutarate, or through succinate. The primary route of glutamine into the TCA cycle is 
through the conversion to glutamate by glutaminase. Glutamate dehydrogenase then 
converts glutamate to α-ketoglutarate, which then continues into the TCA cycle to be 
converted into glutamate. 
The other path for glutamine to enter the TCA cycle is through conversion of 
glutamate into GABA, a neuroinhibitory neurotransmitter. Glutamate is converted into 
GABA by glutamate decarboxylase, and then converted into succinate semialdehyde. 
Finally, succinate semialdehyde is converted into succinate and can enter the TCA cycle 
or perform other functions. This non-canonical pathway for succinate synthesis in 
immune cells has been shown in BMDM. GABA was detected by mass spectrometry in 
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BMDM and 13C-labeled succinate was detected after culturing BMDM with 13C-labeled 
glutamine, indicating the use of this pathway in immune cells (Tannahill et al., 2013). 
GABA has also been implicated in modulating T cell function, having been reported to 
reduce T cell proliferation and inhibit Th1 cell responses (Bhat et al., 2010; Bjurstom et 
al., 2008; Tian et al., 2004). 
1.4.4 Fatty acid oxidation 
 Fatty acid oxidation, also known as β oxidation, is the process through which fatty 
acids are broken down into individual acetyl-CoA molecules that can enter the TCA 
cycle. Fatty acid oxidation begins in the cytosol with the addition of coenzyme A (CoA) 
to a fatty acid by acyl-CoA synthetase. This process creates an acyl-CoA and requires 
one ATP molecule to complete. Fatty acid oxidation occurs in the mitochondria, but acyl-
CoA molecules cannot be transported into the mitochondria and must first be converted 
to acyl-carnitine. These acyl-carnitine molecules can be transported into the 
mitochondria. Carnitine palmitoyltransferase 1 and 2 (CPT1 and CPT2) are the enzymes 
responsible for translocating fatty acids into the mitochondria. CPT1 is located on the 
external side of the inner mitochondrial membrane and is responsible for converting the 
acyl-CoA into acyl-carnitine. The acyl-carnitine can then be shuttled across the inner 
mitochondrial membrane by a carnitine carrier protein. CPT2, located in the 
mitochondrial matrix, converts acyl-carnitine back into acyl-CoA. The free carnitine is 
then transported out of the matrix by the carnitine carrier protein. 
 Once in the mitochondrial matrix, the acyl-CoA undergoes fatty acid oxidation. 
This is a four-step process that results in the release of one acetyl-CoA molecule from the 
fatty acid chain. Fatty acid oxidation generates energy not only by adding acetyl-CoA to 
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the carbon pool for the TCA cycle, but also through the release of that acetyl-CoA. Two 
steps in the process, reactions catalyzed by acyl-CoA dehydrogenase and 3-L-
hydroxyacyl-CoA dehydrogenase, generate FADH2 and NADH, respectively. These 
cofactors can then donate electrons to the ETC. Fatty acid oxidation ends with the 
addition of a CoA molecule onto the acyl chain, regenerating acyl-CoA. The acyl-CoA, 
now two carbons shorter due to the release of acetyl-CoA, can undergo another round of 
fatty acid oxidation. The whole process repeats until the fatty acid is fully oxidized. 
1.4.4.1 The role of fatty acid oxidation in immune cells 
 Fatty acid oxidation is generally considered a contributor to the anti-inflammatory 
state of immune cells. In macrophages, CPT1A (an isoform of CPT1) expression has 
been shown to be correlated with increased fatty acid oxidation. Overexpression of the 
protein in macrophages resulted in the increase of fatty acid oxidation and the decrease of 
pro-inflammatory molecules, such as IL-1β (Malandrino et al., 2015).  
In T cells, fatty acid oxidation has been shown to be important for both memory T 
cell and Treg cell generation. CD8+ T cells that have been shifted to a memory phenotype 
through supplementation of the culture medium with IL-15 display increased fatty acid 
oxidation and OXPHOS, which is important for maintaining that memory state. Memory 
CD8+ T cells use glucose to generate fatty acids, which are then used to support 
OXPHOS via fatty acid oxidation (O'Sullivan et al., 2014). IL-15-generated memory-like 
CD8+ T cells also express a greater amount of CPT1A compared to effector cells and 
blocking CPT1A with the drug etomoxir results in a decrease in OXPHOS (O'Sullivan et 
al., 2014; van der Windt et al., 2012). Treg cells generated in vitro were shown to have 
increased OXPHOS and fatty acid oxidation, as measured by oxidation of radiolabeled 
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palmitate, which was decreased with etomoxir treatment. Th17 cells, compared to Treg 
cells, undergo less fatty acid oxidation and more glycolysis (Michalek et al., 2011). 
1.4.5 Oxidative phosphorylation 
 Unlike the previously mentioned metabolic pathways, oxidative phosphorylation 
(OXPHOS) is not a series of enzymatic reactions that are responsible for the catabolism 
or anabolism of metabolites. OXPHOS encompasses glycolysis, the TCA cycle, and 
electron transport. The name oxidative phosphorylation refers to the oxidation of glucose 
and TCA intermediates which results in the phosphorylation of ADP to create ATP. The 
key to the whole process is the transfer of electrons between protein complexes and 
ultimately to oxygen. This process results in the generation of a proton gradient across 
the inner mitochondrial membrane which is needed for complex V, or ATP synthase, to 
generate ATP from ADP. Having covered the “oxidative” half of OXPHOS in the 
previous sections, the next section will focus on the second half, that is electron transport 
and ATP synthesis. 
1.4.5.1 The electron transport chain 
 The electron transport chain (ETC) is composed of five different protein 
complexes in the inner mitochondrial membrane: complex I (NADH-coenzyme Q 
oxidoreductase), complex II (succinate-coenzyme Q oxidoreductase), complex III 
(coenzyme Q-cytochrome c oxidoreductase), complex IV (cytochrome c oxidase), and 
complex V (ATP synthase). Electrons removed at various points during glycolysis, the 
TCA cycle, and fatty acid oxidation, are transported to the ETC in the form of the 
cofactors NADH and FADH2 (Fig 1.4). NADH donates electrons to complex I, where the 
electrons traverse the complex through a series of coenzymes and iron-sulfur redox 
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centers before being transferred to coenzyme Q (CoQ). The process of moving electrons 
from NADH to CoQ results in the translocation of protons from the matrix of the 
mitochondria to intermembrane space. Complex II, which also contains succinate 
dehydrogenase, transfers electrons from succinate to CoQ, using FAD as the initial 
cofactor. Electrons are transferred to FAD to generate FADH2, which then transfers the 
electrons to redox centers in the complex before finally reducing oxidized CoQ. Reduced 
CoQ, generated either at complex I or complex II, transports electrons to complex III 
through the lipid bilayer. Complex III then transfers the electrons from CoQ to 
cytochrome C, translocating protons to the intermembrane space in the process. 
Cytochrome c then transfers the electrons to complex IV, where the electrons are used to 
reduce oxygen to water. Complex IV also translocates protons to the intermembrane 
space in the process of reducing oxygen. 
 The purpose of the electron transport chain is to translocate protons from the 
mitochondrial matrix to the intermembrane space. This creates an electrochemical 
gradient of protons and charge, with the intermembrane space being much more 
positively charged than the matrix. This gradient, called the proton motive force or 
mitochondrial membrane potential, is what allows complex V of the ETC to generate 
ATP. Complex V allows protons to flow back down this gradient while using the energy 
of that proton flow to phosphorylate ADP. Protons enter the matrix, where they are again 
translocated through the complexes of the ETC, replenishing the electrochemical 
gradient. 
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1.4.5.2 The role of oxidative phosphorylation in immune cells 
 OXPHOS is often referred to as an opposing metabolic state from glycolysis in 
immunometabolism literature. This can be misleading, as OXPHOS can encompass 
glycolysis through the oxidation of carbons derived from glucose. Therefore, the term 
OXPHOS has taken on a related meaning of mitochondrial respiration. Since oxygen is 
the final electron acceptor in OXPHOS, measurements of oxygen consumption by cells 
can be used as a proxy measurement of mitochondrial respiration and electron transport. 
Electron transport is directly tied to the TCA cycle through the oxidation of FADH2 and 
NADH, so an increase in oxygen consumption is considered to be linked to an increase in 
carbon flow through the TCA cycle, and electron transport. 
Figure 1.4: Electron transport chain 
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 T cells will switch between OXPHOS and glycolysis during an immune response. 
Both naïve and memory T cells are known to favor OXPHOS as the primary metabolic 
pathway of homeostasis (van der Windt et al., 2012). These metabolic differences are not 
only seen between effector and non-effector T cells, but also between subsets, 
particularly in the CD4+ T cells. Th1 and Th2 cells favor glycolysis, whereas Treg cells 
favor OXPHOS. Th17 cells appear to utilize both glycolysis and OXPHOS. Th17 and T 
reg cells even utilize different sources of fatty acids to fuel mitochondrial metabolism, 
with Treg cells importing fatty acids and Th17 cells making fatty acids to use in fatty acid 
oxidation (Berod et al., 2014a; Michalek et al., 2011). This difference in fatty acid 
generation could be one reason for the different glycolytic states between these two 
subsets. 
 Similar to T cells, macrophages also favor different metabolic states depending on 
function. M1 macrophages utilize glycolysis when activated, which is thought to promote 
the quick response these cells need for antibacterial responses. Conversely, M2 
macrophages utilize OXPHOS. This is thought to help the cells maintain survival and 
effector function for a much longer period, allowing these cells to better fight parasites 
such as helminths (O'Neill et al., 2016; O'Neill and Pearce, 2016). Considering the 
differences in metabolism between macrophage and T cell subsets, it can be appreciated 
that metabolism plays an important role in the function of immune cells. 
1.5 Methylation-controlled J-protein 
 Methylation-controlled J-protein (MCJ) is a 15-17 kDa member of the DNAJ 
family of proteins encoded by the gene dnajc15 (Hatle et al., 2007; Shridhar et al., 2001). 
DNAJ proteins can perform a variety of functions from protein folding to protein 
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regulation. Expression of MCJ is regulated through DNA methylation, and expression is 
decreased when CpG rich regions within the gene are methylated (Shridhar et al., 2001; 
Strathdee et al., 2004). MCJ is highly expressed in the heart, liver, kidneys, and testis. In 
the immune system, MCJ is expressed in T cells, though at a much higher level in CD8+ 
T cells compared to CD4+ T cells (Hatle et al., 2013). Low expression of MCJ has been 
correlated with increased chemoresistance in some cancers due to excretion of the 
chemotherapeutic from the cell. When MCJ is re-expressed in these cancer cells, 
chemotherapeutics are retained within the cell, making the cancers chemosensitive (Hatle 
et al., 2007; Shridhar et al., 2001). 
1.5.1 Structure, location, and function 
 MCJ is a unique member of the DNAJ family of proteins. Similar to other DNAJ 
family members, MCJ contains a DNAJ domain, though it is located at the C-terminus as 
opposed to the N-terminus. The N-terminus of MCJ is unique among the DNAJ family 
members. MCJ also contains a transmembrane domain, unlike many DNAJ family 
members (Hatle et al., 2013; Hatle et al., 2007). 
 MCJ is located in mitochondria, and the transmembrane domain allows the 
protein to associate with the inner mitochondrial membrane (Hatle et al., 2013) where 
MCJ performs its function as a regulator of mitochondrial metabolism. MCJ associates 
with complex I of the electron transport chain (Hatle et al., 2013) and reduces electron 
flow through the electron transport chain (ETC) by reducing both complex I activity and 
supercomplex formation (Hatle et al., 2013). Supercomplexes are associations of 
complexes I, III, and IV of the ETC. These supercomplexes can have a variety of 
combinations (e.g. supercomplex I/III/IV or supercomplex I/III) and can even contain 
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multiples of a complex (e.g. supercomplex I/III2/IV, where the subscript denotes the 
number of a given complex) (Vartak et al., 2013). MCJ was found to reduce 
supercomplex formation, which is thought to reduce the efficiency and rate of electron 
flow through the ETC (Hatle et al., 2013). 
1.5.2 Role in the immune system 
 Studies on the role of MCJ in the immune system have been carried out primarily 
through the use of mice deficient in MCJ (Hatle et al., 2013). As a negative regulator of 
complex I, it was not surprising that the loss of MCJ in CD8+ T cells resulted in an 
increase in oxygen consumption in mitochondria, increased ATP production, and an 
accumulation of amino acids (Champagne et al., 2016). MCJ-deficiency increased 
cytokine secretion in activated CD8+ T cells. Loss of MCJ. Loss of MCJ in CD8+ T cells 
had no effect on cell proliferation or death immediately after activation in vitro, but did 
allow activated effector T cells to survive after cytokine withdrawal, which is one 
mediator of apoptotic death (Champagne et al., 2016; Snow et al., 2010). The ability to 
withstand cytokine withdrawal could potentially explain the fact that MCJ deficient CD8+ 
T cells have an increased memory response to viral infection (Champagne et al., 2016). 
While it is apparent that MCJ affects the metabolism and memory function of T cells, it is 
not clear why the loss of MCJ promotes the survival of CD8+ T cells. 
1.6 Cell Death 
 Cell death is an important process in all animals. It plays a key role in many 
aspects of biology, from embryo development to tissue homeostasis and even immune 
responses. For the immune system, cell death is critical during T cell development. In the 
thymus, autoreactive T cells undergo death to eliminate autoreactive T cells. In addition, 
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following an immune response, effector T cells that have proliferated need to die to 
prevent unintentional tissue damage. The timely death of effector T cells is possible due 
to a dramatic increase in susceptibility to death signals once the cell is activated (Green et 
al., 2003; Snow et al., 2010). Emerging evidence suggests that the increased sensitivity is 
linked to the upregulation of glycolysis after T cell activation, though the full mechanism 
of how glycolysis increases sensitivity to death signals is not well understood (Larsen et 
al., 2017). Defects in T cell death can lead to lymphomas as well as autoimmune disease, 
so a better understanding of how susceptibility to cell death is regulated in T cells is 
critical for finding therapeutic interventions for these diseases. 
1.6.1 Forms of cell death 
 There are many ways for a cell to die. Cell death can be split into two general 
categories; necrosis versus apoptosis. Necrotic death occurs through rupture of the 
cytoplasmic membrane and is highly inflammatory. Apoptosis occurs through a 
mechanism initiated by the cell itself or externally by death ligands such as TNF, Fas-
Ligand, or TRAIL. and as such, is often called programmed cell death (Tait et al., 2014). 
Apoptotic cell death can take many forms, and each one utilizes a unique pathway in the 
cell. Some of those pathways utilize caspases whereas others do not. 
 One caspase-independent pathway is necroptosis, which begins with the 
stimulation of a death receptor ligand such as TNF (Degterev et al., 2005). When 
caspase-8 is inhibited, either chemically or by interaction with an inhibitory protein, 
receptor-interacting serine/threonine-protein kinase (RIPK) 1 and 3 will interact at the 
death receptor and become activated. RIPK3 then phosphorylates mixed-lineage kinase 
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domain-like (MLKL), which oligomerizes and forms pores in the plasma membrane, 
leading to necrotic cell death (Murphy et al., 2013; Tait et al., 2014). 
 Ferroptosis is an iron-dependent form of caspase-independent cell death. 
Originally identified through the use of the small molecule erastin, ferroptosis results 
from the inhibition of the glutamate/cystine transporter. This leads to antioxidant 
starvation through the loss of glutathione. The decrease in antioxidants causes an increase 
in oxidative stress and lipid peroxidation, which ultimately induces cell death (Dixon et 
al., 2012; Gao et al., 2018). 
 Autophagic cell death has been documented in various eukaryotes such as slime 
molds and fruit flies but has not been fully appreciated in vivo in mammals. When studied 
in vitro, autophagic cell death is dependent on autophagic proteins such as Beclin-1, 
ATG5, and ATG7. The autophagy pathway can be initiated when other routes of cell 
death are inhibited, such as through the inhibition of capsase-8 or with the loss of BAX 
and BAK (Shimizu et al., 2004; Yu et al., 2004). As autophagy is initiated, ROS and 
oxidative stress will increase in the cell, partly due to the degradation of catalase, and 
induce cell death (Yu et al., 2006). 
 Unlike the previously summarized forms of cell death, pyroptosis is induced by 
caspases. Caspase-1 and caspase-11 (in mouse) are inflammatory caspases that are 
responsible for processing and activating the cytokines IL-1β and IL-18. During 
pyroptosis, DNA is fragmented, and the cell will swell and lyse. It is not completely 
understood why pyroptosis occurs. One reason could be to increase the release of IL-1β 
and IL-18. This process is pro-inflammatory and helps control bacterial infections 
(Bergsbaken et al., 2009; Tait et al., 2014). 
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1.6.2 Apoptosis and caspases 
First defined in 1972 (Kerr et al., 1972), apoptosis is the form of death that cells 
undergo during tissue development, and post-development tissue homeostasis. The term 
“apoptosis” is Greek meaning “falling off” and refers to the way in which flower petals 
or leaves fall off a flower or tree. The “falling off” that happens in cell death is the 
blebbing of small membrane-bound compartments, known as apoptotic bodies, from a 
cell undergoing apoptosis. Apoptosis begins with the condensation of nuclear chromatin 
and fragmentation of DNA, which results in the engulfment and degradation of apoptotic 
bodies by phagocytic cells (Kerr et al., 1972).  
 Apoptosis is mediated by proteases called caspases (cysteine-containing 
aspartate-cleaving proteases). Cleavage of caspases can be done by Caspases involved in 
apoptosis can be sorted into two major groups, upstream initiator caspases that respond to 
death stimuli, and downstream effector caspases that carry out the destruction of the cell. 
Caspases are translated as zymogens, meaning they need to be cleaved to become active. 
Cleavage of caspases is usually done by upstream caspases. In the case of apoptosis, 
effector caspases are cleaved by initiator caspases. Those initiator caspases can be 
activated by other initiator caspases, or they can be activated through a process called 
proximity induced autoactivation (Fig. 1.5). In this method of activation, the inactive 
zymogen has an intrinsic activity and will autocleave when in close proximity to other 
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caspase zymogens. This is the mechanism through which caspase-8 is activated, initiating 
the extrinsic pathway of apoptosis (Muzio et al., 1998). 
 
 Through the extrinsic pathway of apoptosis, an extracellular signal is transduced 
across the cellular membrane to activate caspases and induce apoptosis (Fig 1.6). This 
signal transduction begins with the ligation of a death receptor (e.g. Fas, TNFR, 
TRAILR) with its ligand, which results in oligomerization of the receptor. The death 
receptors contain a cytosolic death domain (DD), which will form a homodimer with the 
DD of the adapter protein Fas-associated death domain protein (FADD) (Boldin et al., 
1995; Chinnaiyan et al., 1995). FADD then recruits pro-caspase-8 or pro-caspase-10 
through dimerization of a death effector domain (DED) found on both FADD and certain 
Figure 1.5: Models of caspase activation 
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caspases. Recruitment of caspases-8 or -10 through DED interactions forms the death-
inducing signaling complex (DISC) (Kischkel et al., 1995; Muzio et al., 1996). The 
caspases in the DISC become active and cleave pro-caspase-3 and/or pro-caspase-7 to 
activate the caspases, which then go on to induce apoptosis. The DISC can also result in 
the activation of the cell intrinsic pathway of apoptosis through the cleavage of BID to 
form active pro-apoptotic tBID (Luo et al., 1998). 
 
Figure 1.6: Extrinsic initiation of apoptosis 
38 
 
In the intrinsic pathway of apoptosis, the release of cytochrome c from the 
mitochondria results in the activation of the caspase cascade. This process begins with the 
activation or expression of pro-apoptotic molecules, such as PUMA, BID, or BAD, as a 
result of cell stress or damage (Kuwana et al., 2005; Leibowitz and Yu, 2010). The 
presence or activation of these molecules triggers the activation of BAX and/or BAK, 
which form pores in the outer membrane of the mitochondria (Gross et al., 1999). 
Cytochrome c is then released and binds to Apaf-1, forming a complex that can recruit 
pro-caspase-9 through a caspase recruitment domain (CARD) found on both Apaf-1 and 
caspase-9. Once bound to the complex, known as the apoptosome, pro-caspase-9 
becomes active, then cleaves and activates pro-caspase-3 and pro-caspase-7 (Li et al., 
1997; Srinivasula et al., 1998). 
As proteases, the way in which effector caspases execute apoptosis is through the 
cleavage of critical proteins. Caspases can cleave proteins, at particular aspartate 
residues, important in maintaining the cytoskeleton, such as actin, myosin, and filamin 
(Browne et al., 2000; Taylor et al., 2008). While cleavage of the cytoskeleton helps to 
weaken the structural integrity of the cell, the blebbing of the membrane is due to the 
cleavage of a protein called ROCK1, a kinase that increases myosin contraction of actin 
filaments through phosphorylation. Cleavage of ROCK1 by caspases results in a 
truncated form of ROCK1 that has increased kinase activity, resulting in the blebbing of 
portions of the cell that have been structurally weakened through the degradation of the 
cytoskeleton (Coleman et al., 2001). 
ROCK1 has also been implicated in another hallmark of apoptosis, the 
fragmentation of the nuclear envelope. Similar to cell membrane blebbing, ROCK1 
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facilitates the tearing of the nuclear membrane by increasing the activity of myosin (Croft 
et al., 2005). This causes the actin filaments attached to the nuclear envelope to contract 
and pull the envelope apart. This also requires weakening of the nuclear envelope, which 
happens through the cleavage of nuclear lamins by caspases (Orth et al., 1996; Rao et al., 
1996). 
Within the nucleus, DNA also undergoes fragmentation due to caspase-3 cleavage 
of the inhibitor of caspase-activated DNase (ICAD), which is found heterodimerized with 
caspase-activated DNase (CAD). Once liberated from ICAD, CAD fragments nuclear 
DNA (Liu et al., 1997; Taylor et al., 2008), which is important to prevent the activation 
of the innate immune system and autoinflammatory disease (Kawane et al., 2003; Napirei 
et al., 2000). 
In addition to the nuclear degradation, the Golgi apparatus, ER, and mitochondria 
are fragmented during apoptosis. While the fragmentation of the Golgi and ER are 
dependent on caspases, mitochondrial degradation is due to the disruption of the 
mitochondrial membrane by BAX and BAK (Taylor et al., 2008). Ultimately, the 
fragmentation of these organelles, along with the proteolysis of the cytoskeleton and 
blebbing of the membrane, allow the apoptotic cell to break into smaller apoptotic bodies 
that can be engulfed by phagocytes. 
Since the intracellular components of the dying cell are contained within the 
apoptotic bodies, apoptosis is considered a non-inflammatory form of cell death. In fact, 
phagocytes have been shown to release anti-inflammatory molecules (IL-10, TGF-β), and 
reduce the production of pro-inflammatory molecules (IL-12, IL-1β, TNF-α) upon 
phagocytosis of apoptotic bodies (Fadok et al., 1998; Kim et al., 2004; Nagata, 2018). 
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Efferocytosis, or the phagocytosis of apoptotic bodies, is potentially so important for the 
regulation of the immune system during tissue homeostasis that dysregulation of this 
process has been suggested to induce autoimmune diseases such as systemic lupus 
erythematosus (SLE) (Hanayama et al., 2004; Nagata et al., 2010; Ravichandran, 2010). 
Recent evidence suggests efferocytosis is a specialized type of phagocytosis called LC3-
associated phagocytosis, which recruits autophagy machinery to complete the 
phagocytosis of apoptotic bodies (Martinez et al., 2016). 
1.6.3 Anti-apoptotic and pro-apoptotic molecules 
 Mitochondria play an important part of the intrinsic apoptotic pathway. The 
release of cytochrome c from mitochondria contributes to the formation of the 
Apoptosome, which also includes caspase-9 and ATP. This leads to activation of 
downstream effector caspases and cell death. Due to the implications of mitochondrial 
integrity in cell death, there are many proteins in the cell involved in preventing or 
promoting death through mitochondrial disruption. These proteins are members of the B-
cell lymphoma-2 (BCL-2) family of proteins. 
 BCL-2 proteins can be divided into two categories: anti-apoptotic and pro-
apoptotic. All members of the BCL-2 family contain at least one BCL-2 homology (BH) 
domain. The anti-apoptotic proteins contain four BH domains, while the pro-apoptotic 
proteins contain three BH domains (Leibowitz and Yu, 2010; Taylor et al., 2008). 
 The BCL-2 family functions by interacting with each other to prevent or promote 
cell death. The BCL-2 pro-apoptotic proteins, specifically BAX and BAK, form pores in 
the mitochondrial membrane allowing the release of cytochrome c, as well as 
Smac/DIABLO, which blocks the function of inhibitors of apoptosis (IAPs). The BCL-2 
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anti-apoptotic members, such as BCL-2, MCL-1, and BCL-xL, primarily function by 
preventing the formation of BAX/BAK pores the outer mitochondrial membrane. This 
can happen through the direct interaction with BAX/BAK, or by binding to BH3-only 
proteins that can promote BAX/BAK oligomerization (Antonsson and Martinou, 2000; 
Leibowitz and Yu, 2010; Taylor et al., 2008). 
 Members of the BCL-2 family are not the only proteins that are involved in 
apoptosis. Some proteins induce apoptosis by activating caspases, such as apoptotic 
protease activating factor 1 (Apaf-1), which promotes the activation of caspase-9 (Li et 
al., 1997; Srinivasula et al., 1998). Others prevent apoptosis by binding to pro-apoptotic 
proteins, such as ICAD which binds to CAD to prevent DNA fragmentation (Liu et al., 
1997; Taylor et al., 2008). Apaf-1 and ICAD, along with many other pro- and anti-
apoptotic proteins, either activate or are cleaved by caspases. 
1.6.4 Non-death functions of caspases 
 Caspases are known as inducers of cell death, but some caspases have functions 
that are not related to cell death. For instance, caspase-3 is important for the 
differentiation of skeletal muscle as it is required for the cleavage and activation of 
mammalian sterile twenty-like kinase, which is critical in the differentiation process 
(Fernando et al., 2002). Caspase-3 also helps to negatively regulate B cell cycling by 
cleaving p21, which can increase cycling in B cells (Woo et al., 2003). Some caspases 
were even discovered for their non-death functions. Caspase-1 was initially discovered as 
a protease that cleaves pro-IL-1 into the proinflammatory cytokine IL-1β and caspase-11 
was found to be involved in the processing of another proinflammatory cytokine, IL-18 
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(Black et al., 1989; Viganò and Mortellaro, 2013; Wang et al., 1996). While both 
caspases can induce death via pyroptosis, cytokine processing is their canonical function. 
 Caspase-8 is needed to transduce death signals through death receptors. However, 
caspase-8 is also necessary for the proliferation in T cells upon TCR stimulation (Misra et 
al., 2007). This makes caspase-8 interesting because these two opposing functions are 
dependent upon the location of caspase-8 in the cell. During activation and T cell 
proliferation, caspase-8 is located in lipid rafts at the plasma membrane. When Fas is 
stimulated to induce cell death, caspase-8 is found in the cytosol of the cell (Koenig et al., 
2008). The location of the caspase is just as important as its activation state when 
considering the function of the enzyme. 
1.6.5 Posttranslational regulation of caspases 
 Posttranslational modifications are changes made to proteins after they are 
synthesized and can range from cleavage to the addition of a small molecule to an amino 
acid. Some posttranslational modifications, such as phosphorylation, can change the 
function of the protein, while others will lead to the destruction of the protein (i.e. 
polyubiquitylation). Caspases normally undergo at least one posttranslational 
modification, which is the cleavage or the protein into an active state. Other 
posttranslational modifications have been reported for caspases, specifically caspase-3. 
Since caspases have a cysteine that functions as the proteolytic residue of the enzyme, 
any modification of that cysteine can inactivate the caspase. Cysteines are particularly 
sensitive to redox-dependent posttranslational modifications, such as s-nitrosylation and 
glutathionylation. Caspase-3 has been shown to be inactivated by both s-nitrosylation and 
glutathionylation, and s-nitrosylation of caspase-3 was reported to be important for 
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maintaining T cell survival in the presence of IL-15 (Huang et al., 2008b; Mannick, 2007; 
Mitchell et al., 2007; Saligrama et al., 2014). 
1.7 Glutathionylation 
 Oxidative stress caused by reactive oxygen species (ROS) can induce a variety of 
deleterious aberrations in cells, such as irreversible protein damage, DNA damage, lipid 
peroxidation, and cell death (Perl, 2013). Cells have several antioxidant mechanisms 
through which they can reduce oxidative stress. One of the most important of these 
mechanisms is the use of glutathione (γ-glutamyl-cysteinyl-glycine). This tripeptide 
exists in both the reduced (GSH) and oxidized (GSSG) state and can be converted 
between the two states by glutathione reductase or thioredoxin and thioredoxin reductase 
(Deponte, 2013). Glutathione has two main functions in reducing oxidative stress. It can 
function as an antioxidant by reducing ROS and forming GSSG, and by protecting 
proteins from over-oxidation (Popov, 2014). 
 Thiols (R-SH), often those found on cysteines, are very sensitive to oxidative 
stress. Due to this sensitivity, the cell will add glutathione to the thiol to protect it from 
irreversible oxidation. Glutathionylation is mediated by glutathione S-transferases and 
deglutathionylation is mediated by glutaredoxin, thioredoxin, and sulfiredoxin (Tew and 
Townsend, 2012). Thiols can be modified when in a reduced state (-SH) or a mildly 
oxidized sulfenyl state (-SOH) (Giustarini et al., 2004). The result of protein 
glutathionylation is a protein modified with a glutathione moiety, which can be actively 
removed by the cell. 
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1.7.1 Synthesis of glutathione 
 Glutathione is composed of three amino acids: glutamate, cysteine, and glycine. 
The first step in the synthesis of glutathione is to ligate glutamate and cysteine. This is 
done by glutamate-cysteine ligase and requires one ATP molecule. This step is also rate-
limiting due to the low concentration of cysteine in the cell (Lu, 2013). The second and 
last step of glutathione synthesis is the addition of glycine by GSH synthase and results in 
the formation of GSH (Lu, 2013). 
1.7.2 Modification of proteins 
 Protein S-glutathionylation serves to both protect proteins from irreversible 
oxidation and to regulate protein function. Glutathione can be added and removed from 
proteins by enzymes, making the modification reversible. Protein glutathionylation can 
change the function of proteins and if the modified cysteine is involved in the activity of 
an enzyme, then the modification may result in inactivation (Giustarini et al., 2004). 
These modifications typically happen when a cell is under oxidative stress. In T cells, 
GAPDH is known to be glutathionylated and its activity is reduced when the cell is under 
oxidative stress (Ghezzi et al., 2002). Previous studies have shown that the oxidative state 
of T cells can change depending on the environment they are in and this oxidative state 
can influence T cell survival (Saligrama et al., 2014). However, further studies are 
needed to fully understand how the environment can affect protein glutathionylation in T 
cells, which proteins are glutathionylated, and how changing the function of those 
proteins impacts the cell. 
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1.8 Dissertation Aims 
 The metabolic state of immune cells is highly important in determining their 
function and fate. Varying the balance of oxidative phosphorylation and glycolysis allows 
a cell to perform different functions, which is exemplified by CD4+ T cell subsets (Berod 
et al., 2014b; Michalek et al., 2011; Pearce and Pearce, 2013). CD8+ T cells are known to 
utilize glycolysis during activation, and oxidative phosphorylation in the memory state 
(Roos and Loos, 1973a; van der Windt et al., 2012), though it is not known how 
metabolism influences the contraction that leads to memory. The work presented in the 
following chapters of this dissertation aims to answer two important questions related to 
T cell metabolism during proliferation and death: 
1. Does metabolism regulate caspase activity in effector T cells? 
2. Are T cell proliferation and contraction linked? 
The answers to these questions will fill the gaps in knowledge of how deeply metabolism 
is integrated into the resolution of the immune response and how the immune system is 
able to mitigate the autoimmune risk associated with the rapid proliferation of effector 
immune cells. 
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2.1 Abstract 
 Resting T cells undergo a rapid metabolic shift to glycolysis upon activation in 
the presence of IL-2, in contrast to oxidative mitochondrial respiration with IL-15. 
Paralleling these different metabolic states are striking differences in susceptibility to 
restimulation induced cell death (RICD); glycolytic effector T cells are highly sensitive to 
RICD whereas non-glycolytic T cells are resistant. It is unclear whether the metabolic 
state of a T cell is linked to its susceptibility to RICD. Our findings reveal that IL-2-
driven glycolysis promotes caspase-3 activity and increases sensitivity to RICD. Neither 
caspase-7, caspase-8, nor caspase-9 activity is affected by these metabolic differences. 
Inhibition of glycolysis with 2-deoxyglucose reduces caspase-3 activity as well as 
sensitivity to RICD. By contrast, IL-15-driven oxidative phosphorylation actively inhibits 
caspase-3 activity through its glutathionylation. We further observe active caspase-3 in 
the lipid rafts of glycolytic but not non-glycolytic T cells, suggesting a proximity-induced 
model of self-activation. Finally, we observe that effector T cells during influenza 
infection manifest higher levels of active caspase-3 than naïve T cells. Collectively, our 
findings demonstrate that glycolysis drives caspase-3 activity and susceptibility to cell 
death in effector T cells independently of upstream caspases. Linking metabolism, 
caspase-3 activity, and cell death provides an intrinsic mechanism for T cells to limit the 
duration of effector function.  
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2.2 Introduction 
 The balance of cell proliferation and cell death is critical for the maintenance of 
stable cell numbers and tissue homeostasis. Thus, it is perhaps not surprising that these 
opposing processes may be mechanistically linked in various cell types, including cancer 
(Evan et al., 1994; Wang et al., 2011). During an immune response, T lymphocytes 
undergo a period of very rapid proliferation. During this expansion, T cells also become 
susceptible to T cell receptor (TCR) restimulation-induced cell death (RICD) (Green et 
al., 2003; Snow et al., 2010). However, the link between proliferation and susceptibility 
to death remains poorly understood (Hedrick et al., 2010). 
 Changes in cellular metabolism are well recognized to play a critical role during 
an effective immune response. Resting naïve T lymphocytes, upon activation, undergo a 
dramatic metabolic shift from oxidative phosphorylation to aerobic glycolysis (Hume et 
al., 1978; Roos and Loos, 1973a; Roos and Loos, 1973b). The switch to a largely 
glycolytic state allows the cell to generate the synthetic capacity needed for rapid 
proliferation and effector function, such as cytokine production. In a similar manner, B 
cells and dendritic cells also utilize glycolysis upon activation to enable their effector 
functions (Santambrogio et al., 2005; Woo et al., 2003). Recent studies have further 
indicated that the metabolic state of effector T cells helps determine their subset 
differentiation (Michalek et al., 2011). Differing metabolic states are also known to be 
involved in the specification of T cell memory, with central memory T cells exhibiting 
high oxidative phosphorylation and effector memory T cells being more glycolytic 
(O'Sullivan et al., 2014; Phan et al., 2016; van der Windt et al., 2012). 
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 It is well appreciated that cell death and metabolism are closely linked. Glycolytic 
enzymes can be induced by the same transcription factors that upregulate the expression 
of anti-apoptotic proteins such as BCL-xL (Green et al., 2014). Other proteins with 
metabolic function, such as cytochrome c, are directly involved in cell death (Green et al., 
2014; Mason and Rathmell, 2011). When released from the mitochondria, cytochrome c 
activates caspase-9, which then cleaves caspase-3 and induces apoptosis. Caspase-3 can 
be alternatively activated through cleavage by caspase-8, which is activated by death 
receptors such as Fas (CD95). However, little is known regarding possible links between 
metabolism and caspase activity.  
 Though caspases were originally defined for their role in cell death, it is now 
appreciated that caspases perform many functions in cells in addition to cell death 
(Lamkanfi et al., 2007; Shalini et al., 2015). This is particularly well established for 
caspase-8, an initiator caspase that can induce apoptosis upon ligation of a death receptor 
(Medema et al., 1997), but can also allow cell proliferation by inhibiting formation of the 
necroptosome and induction of necroptosis (Dillon et al., 2012). Active caspase-3, a 
critical downstream mediator of apoptosis, has also been observed in non-dying cells and 
is implicated in skeletal muscle differentiation (Fernando et al., 2002), T cell anergy 
(Puga et al., 2008), B cell cycling (Woo et al., 2003), and erythrocyte maturation 
(Lamkanfi et al., 2007). However, these studies did not examine how caspase-3 activity is 
being regulated in these non-apoptotic situations. Moreover, an explanation has been 
lacking for the molecular switch between TCR-stimulated proliferation of naïve T cells 
versus induction of cell death in effector T cells (Green et al., 2003; Snow et al., 2010). 
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 Given the involvement of caspases in both cell death and non-death functions, 
regulation of caspase activity and its location in cells are of paramount importance in 
determining cell fate. We have observed that T cells grown in interleukin (IL)-2 versus 
IL-15 have similar amounts of total pro-caspase-3, but IL-2-cultured T cells have a 
substantially higher level of active caspase-3, and as a result are much more susceptible 
to RICD (Saligrama et al., 2014). IL-15-cultured T cells are resistant to this form of cell 
death, in part due to the high levels of reactive oxygen and nitrogen species that lead to 
the redox modification of a critical cysteine in the active site of caspase-3, resulting in its 
inactivation (Huang et al., 2008a; Mitchell and Marletta, 2005a; Saligrama et al., 2014). 
IL-2 and IL-15 also induce very different metabolic states in T cells; IL-2 promotes 
glycolysis, whereas IL-15 upregulates oxidative phosphorylation (van der Windt et al., 
2012). We now observe that caspase-3 activity in non-dying effector T cells is largely a 
function of their glycolytic state. Inhibition of glycolysis by a variety of methods reduces 
caspase-3 activity and protects T cells from RICD. In addition, IL-15-cultured T cells 
further reduce caspase-3 activity through its inactivation by glutathionylation. These 
findings underscore the importance of cellular metabolism in the regulation of caspase-3 
activity and susceptibility toward cell death. 
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2.3 Results 
2.3.1 IL-15 induces mitochondrial ROS and glutathionylation of caspase-3 
 To investigate the influence of cell metabolism on caspase activity, we initially 
modeled two metabolic states in vitro using cytokines that are known to promote very 
different levels of glycolysis following T cell activation: IL-2, which upregulates 
glycolysis, and IL-15, known to induce a non-glycolytic state of mitochondrial 
respiration (van der Windt et al., 2012). To mimic an immune response in vitro, purified 
naïve T cells were activated with anti-CD3/CD28 in the presence of IL-2 for 2 days, then 
removed from stimulation and propagated in IL-2 for an additional day. The activated T 
cells were then washed thoroughly to remove exogenous cytokines and recultured in 
medium containing either IL-2 or IL-15 for an additional 3 days. In agreement with 
previous observations (van der Windt et al., 2012), IL-15-cultured T cells manifested 
high mitochondrial respiration, as reflected by a high oxygen consumption rate (OCR) 
(Fig. 2.1A). Consistent with these findings, complex I activity of the electron transport 
chain was higher in IL-15-cultured T cells than in IL-2-cultured T cells (Fig. 2.1B and C). 
Complex I is known to generate reactive oxygen species (ROS) (Grivennikova and 
Vinogradov, 2006), and we determined that IL-15 induced a greater amount of 
mitochondrial ROS compared to IL-2 (Fig. 2.1D) as measured using the mitochondria-
targeted probe mitoboronic acid (MitoB) (Cochemé et al., 2011). MitoB is converted to 
mitophenol (MitoP) upon reaction with mitochondrial hydrogen peroxide, and the levels 
of MitoB and MitoP are then measured by liquid chromatography tandem mass 
spectrometry and expressed as a ratio of MitoP to MitoB (Cochemé et al., 2011). 
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 ROS can promote protein glutathionylation, a process that results in the reversible 
modification of a cysteine by glutathione (Giustarini et al., 2004). Caspase-3 has been 
shown previously to be inactivated in HL-60 cells by the glutathionylation of the critical 
cysteine in the enzymatic pocket (Huang et al., 2008a). We therefore investigated the 
possibility that caspase-3 is glutathionylated in IL-15-cultured T cells. Glutathionylated 
proteins were immunoprecipitated and immunoblotted for caspase-3 (Fig. 2.2A). 
Caspase-3 was glutathionylated to a considerably greater extent in the IL-15-cultured T 
cells compared to IL-2 (Fig. 2.2B). Of interest, the glutathionylation was observed 
specifically on cleaved caspase-3 (Fig. 2.2A). This implies that full-length pro-caspase-3 
was initially cleaved and then inactivated by glutathionylation. 
 Given that IL-15 induced a greater amount of mitochondrial ROS compared to IL-
2 (Fig. 2.1D), we examined the effect of quenching mitochondrial ROS on overall 
caspase activity in activated T cells. IL-2- and IL-15-cultured T cells were incubated with 
the mitochondria-targeted antioxidant mitoquinone (MitoQ) to quench mitochondrial 
ROS (Kelso et al., 2001). MitoQ treatment of IL-15-cultured T cells, but not IL-2-
cultured T cells, induced a reduction in ROS (Fig. 2.2C). The lack of effect of MitoQ in 
IL-2-cultured T cells may reflect a non-mitochondrial source of ROS, such as 
cytoplasmic NADPH oxidases. Consistent with these findings, MitoQ did not alter 
caspase activity in IL-2-cultured T cells, but did slightly increase caspase activity in IL-
15-cultured T cells, though not to the level of caspase activity in IL-2-cultured T cells 
(Fig. 2.2D). Consistent with these findings, treatment with MitoQ did not affect the 
sensitivity of IL-2- or IL-15-cultured T cells to death, either before or after restimulation 
(Fig. 2.2E). Thus, mitochondrially-derived ROS partially contributed to the low level of 
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caspase activity in IL-15-cultured T cells, but were not solely responsible for the 
decreased sensitivity to RICD. We therefore considered that the pronounced metabolic 
shift to glycolysis during T cell activation might also influence the activity of certain 
caspases and sensitivity to RICD. 
2.3.2 Glycolysis drives caspase-3 activation 
 Glycolysis was measured by extracellular acidification rate (ECAR) in naïve T 
cells, effector T cells (day 6 after activation), and late effector T cells (day 10 after 
activation). Glycolysis increased initially from naïve to day 6 T cells, then decreased 
from day 6 to day 10 (Fig. 2.3A). These changes were greater in the IL-2-cultured T cells 
than IL-15. IL-2 signaling is known to drive glycolysis (van der Windt et al., 2012), and 
the kinetics of glycolysis in T cells grown in IL-2 closely paralleled the levels of surface 
IL-2 receptor α (CD25) expression, which also peaked and declined over a nearly 
identical time span (Fig. 2.3B). These results are consistent with previously reported 
kinetics of CD25 expression (Cantrell and Smith, 1983). Concomitant with the rise of 
glycolysis and surface CD25 expression following T cell activation, we observed an 
increase in total caspase activity. T cells propagated in IL-2 continued to increase caspase 
activity until a peak at day 6, after which it declined through day 10, closely paralleling 
ECAR and CD25 expression (Fig. 2.3C). As a result of the culturing system and the 
introduction of IL-15 at day 3, the first measurements of caspase activity and CD25 
expression occurred on day 4 for IL-15-cultured T cells. In the presence of IL-15, CD25 
expression and caspase activity remained at a consistently low level throughout the same 
10-day period (Fig. 2.3C). The largest difference in caspase activity between IL-2- and 
IL-15-cultured T cells was at day 6. We also measured the level of active caspase-3 by 
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flow cytometry, and found it to be greater in IL-2-cultured T cells compared with IL-15-
cultured T cells at day 6 (Fig. 2.3D). Whereas caspase-3 activity was detected in live IL-
2-cultured T cells, activity was much higher in cells in which death was induced through 
Fas stimulation (Fig. 2.3D). Thus, the intermediate levels of active caspase-3 in 
proliferating T cells were not due to contaminating dead cells, but rather were present in 
all IL-2-cultured T cells. 
 To extend the observed correlation of glycolysis with caspase activity, we 
examined CD4+ T cell functional subsets, which have been shown to have varying levels 
of glycolytic activity (Michalek et al., 2011). In vitro-differentiated T helper (Th)1 and 
Th2 cells were reported to have high levels of glycolysis, being slightly higher in Th2 
cells. By contrast, in vitro-differentiated T regulatory (Treg) cells had low levels of 
glycolysis. Purified naïve CD4+ T cells were differentiated into Th1, Th2, and Treg cells 
in vitro and their caspase activity was measured. Caspase activity was highest in the Th2 
subset and lowest in the Treg subset, matching glycolytic activity (Fig. 2.3E and F). 
 These collective findings suggested that glycolysis and caspase activity might be 
causally linked. We thus examined more directly the effect of glycolysis on caspase 
activity. To inhibit glycolysis, IL-2-cultured T cells were incubated with 2-deoxy-D-
glucose (2-DG), a glucose analog that blocks glucose catabolism after phosphorylation by 
hexokinase (Wick et al., 1957). As an inhibitor of glycolysis, 2-DG could potentially 
induce cell death in highly glycolytic IL-2-cultured T cells. To reduce contamination by 
dead cells, the 2-DG cell cultures were centrifuged over Histopaque. The inhibition of 
glycolysis by 2-DG was confirmed by measuring a decrease in ECAR (Fig. 2.4A). In 
parallel, caspase activity was also decreased, in a dose-dependent manner, in IL-2-
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cultured T cells cultured with 2-DG (Fig. 2.4B). To confirm that the decrease in caspase 
activity was due to the inhibition of glycolysis and not an off-target effect of 2-DG, we 
also inhibited glycolysis by two other methods, culturing IL-2-cultured T cells with 
rapamycin or in a low-glucose medium. These treatments also reduced caspase activity in 
IL-2-cultured T cells (Fig. 2.4B) but not in IL-15-cultured T cells (Fig. 2.4C). 
 To determine whether the regulation of caspase activity by glycolysis was 
selective for certain caspases, we examined the levels of specific caspase activity in IL-2-
cultured T cells in the presence or absence of 2-DG, using biotin-VAD (bVAD) to 
selectively precipitate only active caspases with streptavidin-coated Sepharose beads. 
Immunoblot analysis of the precipitates revealed that 2-DG caused a profound decrease 
in caspase-3 activity, but had no effect on the activities of the related effector caspase-7, 
nor the upstream caspase-8 or caspase-9 (Fig. 2.5A and B). The disparate levels of active 
caspase-3 in glycolytic versus non-glycolytic T cells suggested they might differ in their 
susceptibility to cell death following TCR restimulation. Day 6 IL-2-cultured T cells 
cultured with and without 2-DG were restimulated with anti-CD3. While 2-DG induced 
more cell death prior to restimulation (Fig. 2.5C), the 2-DG-treated cells were 
considerably more resistant to restimulation-induced cell death (RICD) (Fig. 2.5D). 
RICD is primarily mediated by Fas-ligand (FasL) signaling (Alderson et al., 1995). 
Therefore, we measured FasL by western blot and found expression to be highest in 
glycolytic IL-2-cultured T cells, and slightly less in non-glycolytic IL-15-cultured and 2-
DG-treated T cells (Fig. 2.5E and F). However, the fact that the activities of caspases-8 
and -9 were not affected by 2-DG suggests that FasL did not mediate caspase-3 activity 
in viable IL-2-cultured T cells. 
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2.3.3 Active caspase-3 is sequestered in membrane lipid rafts in effector T cells 
 Self-cleavage of caspases can occur when pro-caspases are clustered in close 
proximity (Muzio et al., 1998), such as in lipid rafts where caspase-8 is known to be 
active in effector T cells (Koenig et al., 2008; Misra et al., 2007). To determine if 
caspase-3 was localized to membrane lipid rafts in effector T cells, lipid rafts were 
purified from both glycolytic, IL-2-cultured T cells, and non-glycolytic, IL-15-cultured T 
cells and the resulting fractions were analyzed for caspase-3 cleavage and activity. In IL-
2-cultured glycolytic T cells, pro-caspase-3 was present primarily in the non-raft 
fractions, and to a much lesser extent in the raft fractions (Fig. 2.6A, raft fractions: 3-5; 
non-raft fractions: 10 and 11). However, caspase-3 was extensively cleaved only in the 
lipid raft fractions. In the IL-15-cultured non-glycolytic T cells, pro-caspase-3 was also 
found predominantly in the non-raft fractions. Although caspase-3 was also observed to 
be cleaved primarily in the raft fractions of IL-15-cultured T cells, it was to a lesser 
extent than in IL-2-cultured T cells (Fig. 2.6B). Hence the ratio of cleaved caspase-3 to 
pro-caspase-3 was greater in the lipid rafts of IL-2-cultured glycolytic T cells than in non-
glycolytic IL-15-cultured T cells (Fig. 2.6C). 
 To confirm that the cleaved caspase-3 observed in lipid rafts was active, we 
performed a bVAD precipitation on the lipid raft fractions 3-5 and the non-raft fraction 
11. Caspase-3 was found to be active at a much greater extent in the raft fractions of IL-
2-cultured glycolytic T cells, compared with IL-15-cultured non-glycolytic T cells (Fig. 
2.6D and E). 
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2.3.4 Caspase-3 activity increases in effector T cells during influenza infection 
 To determine whether active caspase-3 is observed in activated T cells in vivo, 
mice were infected intranasally with influenza virus strain A/Puerto Rico/8/1934 H1N1 
(Flu) and lymphocytes from the lung-draining mediastinal lymph node were analyzed 
after 6 days. Caspase-3 activity was measured in naïve (CD44low) and proliferating 
effector (CD44high) CD4+ and CD8+ T cells (Fig. 2.7A). The percentage of active caspase-
3-positive cells, as well as the median fluorescence intensity (MFI) of active caspase-3 
staining, were increased in the CD44high population of both CD4+ and CD8+ T cells after 
Flu infection, compared to the CD44low population (Fig. 2.7B). 
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2.4 Discussion 
 The present findings reveal that IL-2-mediated glycolysis increases caspase-3 
activity and the consequential susceptibility of effector T cells to caspase-3-mediated cell 
death. IL-15, by contrast, drives low levels of glycolysis that favor low caspase-3 
activity. The high amount of oxidative metabolism in IL-15-cultured T cells also 
promotes a further decrease in caspase-3 activity through its glutathionylation. Our data 
support a model by which glycolytic metabolism sets the stage for a high proliferative 
rate of effector T cells that is coupled to enhanced susceptibility to death cues through the 
activity of downstream effector caspase-3. 
 Cleavage of caspase-3 can be induced by upstream caspase-8 following Fas 
ligation, and by caspase-9 following cytochrome c release from the mitochondria. It is 
also possible for cleavage of caspase-3 to occur by self-activation when caspase-3 
molecules are clustered in close proximity (Muzio et al., 1998; Shi, 2004). We observed 
that the levels of both caspase-8 and caspase-9 activity were similar between glycolytic 
and non-glycolytic T cells suggesting that they are not likely to be the regulators of 
caspase-3 activity in these different metabolic states. The findings are also consistent 
with our previous observations that caspase-3 activity persists in effector T cells in which 
caspase-8 was deleted (Koenig et al., 2014). It is possible that translocation to the cell 
membrane, and particularly to lipid raft domains, allows the clustering of full-length 
inactive caspase-3, and could promote its proximity-induced autocleavage and activation 
(MacCorkle et al., 1998; Shi, 2004). Furthermore, while confined to lipid rafts, active 
caspase-3 may also be restricted in its access to substrates that might induce cell death. 
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 Effector T cells and memory T cells have very different metabolic profiles. 
Similar to memory T cells derived in vivo, memory-like T cells can be generated in vitro 
through IL-15 signaling that promotes oxidative phosphorylation (O'Sullivan et al., 2014; 
van der Windt et al., 2012). Consistent with those previous reports, we observed that 
compared to IL-2, IL-15-cultured T cells have elevated oxidative phosphorylation and 
mitochondrial ROS. Our findings further reveal that IL-15-cultured T cells manifest 
glutathionylation of caspase-3, which is known to inactivate caspase-3 at the critical 
cysteine in the enzymatic pocket (Huang et al., 2008a). Given that glutathionylation of 
caspase-3 was detected only of cleaved caspase-3 in IL-15-cultured T cells, this suggests 
that caspase-3 is being inactivated by glutathionylation after its cleavage. Along with our 
previous report of the inactivation of caspase-3 by S-nitrosylation (Saligrama et al., 
2014), these data show that in T cells, caspase-3 can be inactivated by redox-dependent 
post-translational modifications, which are influenced by the metabolic state of the cell. 
Metabolically-induced modifications of apoptotic caspases may be an important 
mechanism for memory T cell formation. 
 The correlation between glycolysis and CD25 expression for in vitro-generated 
effector T cells is not surprising given the known role of IL-2 in the induction of 
glycolysis in T cells. However, in vitro-differentiated T reg cells, despite expressing high 
levels of CD25, are not glycolytic, likely due to their derivation with TGF (Delisle et 
al., 2013; Michalek et al., 2011). We observed that these cells have low caspase activity, 
indicating that caspase activity is a function of glycolysis rather than CD25 expression. 
Proliferating T cells are known to be susceptible to cell death cues such as RICD 
(Kabelitz and Janssen, 1997; Peter et al., 1997). Our data demonstrate independent 
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increases in both FasL and caspase-3 activity in glycolytic IL-2-cultured T cells prior to 
TCR restimulation. Consistent with our observations, a study recently reported that 
human CD8+ T cells rapidly induced FasL protein following TCR restimulation only 
when glycolytic, rendering them more susceptible to RICD (Larsen et al., 2017). 
However, we do not feel that the caspase-3 activity or the capase-8 activity in 
proliferating glycolytic T cells is due to Fas/FasL interactions for a few reasons. First, we 
observed no increased levels of active upstream caspase-8 in IL-2-cultured T cells despite 
more active caspase-3. Second, we have previously shown that Fas-deficient effector T 
cells express as much active caspase-8 as wild-type T cells (Misra et al., 2007). Finally, 
reducing caspase-8 activity in effector T cells by deleting its regulator, c-FLIP, had no 
effect on the levels of active caspase-3 (Koenig et al., 2014). Hence, the collective 
findings would indicate that the levels of active caspase-8 and caspase-3 in effector T 
cells are largely independent of one another as well as independent of Fas/FasL 
interactions. 
 At present the full spectrum of function of caspase-3 activity in viable effector T 
cells is unclear. Other reports have noted a role for caspase-3 in T cell anergy (Puga et al., 
2008), cleavage of p21 and cell cycling in B cells (Woo et al., 2003), skeletal muscle 
differentiation (Fernando et al., 2002), and maturation of erythrocytes, macrophages, and 
dendritic cells (Lamkanfi et al., 2007). The localization of active caspase-3 in membranes 
could provide access to substrates important to these functions, while simultaneously 
preventing the enzyme from cleaving pro-death substrates. While it is possible that the 
glycolytic state of cells may influence these other reported functions of caspase-3, the 
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current findings nonetheless link metabolism to caspase-3 activity and thus provide a 
plausible regulatory mechanism of immune cell homeostasis. 
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2.5 Materials and Methods 
Mice 
 C57BL/6NJ male mice (Jackson Laboratory, Bar Harbor, ME) were housed in an 
Association for Assessment and Accreditation of Laboratory Animal Care International-
approved facility at the University of Vermont Larner College of Medicine. Mice were 
used at 2-6 months of age and protocols were approved by the Institutional Animal Care 
and Use Committee. 
Cell Culture 
 T cells were purified from mouse lymph nodes (axillary, inguinal, brachial, 
cervical) and spleens by negative selection as described previously (Saligrama et al., 
2014). Briefly, lymph nodes and spleens were homogenized through nylon mesh and red 
blood cells were lysed with Gey’s solution. Combined lymphocytes and splenocytes were 
incubated on ice for 30 min with the following antibodies: anti-CD11b (M1/70), anti-
MHC class II (M5/114/15/2; a kind gift from M Rincón, Larner College of Medicine, 
University of Vermont, Burlington, VT, USA), and anti-B220 (RA3-6B2). Cells were 
then rocked over magnetic goat anti-rat beads (Qiagen, Germantown, MD, USA) at a 
10:1 bead:cell ratio for 45 min at 4°C. Beads and bound cells were removed with a 
magnet. Naïve T cells were cultured in RPMI-1640 (Corning, Manassas, VA, USA), 
supplemented with 25 mM HEPES, 100 U/mL penicillin-streptomycin (ThermoFisher 
Scientific, Waltham, MA, USA), 5% bovine calf serum (GE Healthcare HyClone, Logan, 
UT, USA), 2.5 mg/L glucose, 2 mM glutamine, 10 μg/mL folate, 1 mM pyruvate, and 50 
μM 2-mercaptoethanol (RPMI-C) and stimulated on 10 μg/mL plate-bound anti-CD3 
clone 145-2C11 (Bio X Cell, West Lebanon, NH, USA) and soluble anti-CD28 ascites 
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clone 37-51 (1:1000), supplemented with 50 U/mL IL-2 (Cetus, Emeryville, CA, USA) at 
37°C, 5% CO2. After 2 days, activated T cells were removed from stimulation and 
cultured for an additional day in RPMI-C and 50 U/mL IL-2. Cells were then washed 3 
times to remove cytokines and cultured for 2-3 more days in RPMI-C supplemented with 
either 50 U/mL IL-2 or 20 ng/mL IL-15 (a kind gift from Amgen, Thousand Oaks, CA, 
USA). For studies of the inhibition of glycolysis, T cells were activated for 2 days in 
RPMI-C medium supplemented with 50 U/mL IL-2. Cells were then washed 3 times and 
cultured in RPMI-C medium with 50 U/mL IL-2 and the indicated doses of 2-deoxy-D-
glucose (Sigma-Aldrich, St. Louis, MO, USA) or rapamycin (MP Biomedicals, Solon, 
OH, USA) for 3 days, replacing media, cytokine, and inhibitor each day. IL-2-cultured T 
cells cultured in 2-deoxy-D-glucose were centrifuged over Histopaque-1077 (Sigma-
Aldrich) to minimize the number of dead cells in the cultures prior to use in the assays. 
Alternatively, cells were washed and cultured with glucose-free RPMI-1640 (Corning) 
supplemented with 100 U/mL penicillin-streptomycin, 5% bovine calf serum, 2 mM 
glutamine, 10 μg/mL folate, 1 mM pyruvate, and 50 μM 2-mercaptoethanol (GF RPMI-
C). Cells were then cultured in GF RPMI-C supplemented with the indicated decreasing 
concentrations of glucose for 3 days, replacing the media each day. 
Caspase activity assay 
 Caspase activity was measured using the Apo-ONE Homogeneous Caspase-3/7 
Assay Kit (Promega, Madison, WI, USA) according to the manufacturer’s specifications. 
Samples were analyzed using a Synergy HT Plate Reader (BioTek, Winooski, VT, USA). 
Cell lysis and immunoblot analysis 
80 
 
 Cells were lysed for 20 min on ice in Lysis Buffer A (0.5% Nonidet P-40, 150 
mM NaCl, 20 mM Tris-HCl (pH 7.4), 10% glycerol, 2 mM sodium orthovanadate, and 
Complete Protease Inhibitor (Roche Diagnostics, Indianapolis, IN, USA)). Protein 
concentration was determined by Bradford Assay (Bio-Rad, Hercules, CA, USA). 
Lysates were boiled for 5 min in Laemmli loading buffer supplemented with 2-
mercaptoethanol (2-ME). Proteins within the lysates were separated by SDS-PAGE on a 
12% acrylamide gel and transferred to a polyvinylidene difluoride (PVDF) membrane 
(Bio-Rad). Membranes were blocked in 4% milk in Tris-buffered saline with 0.1% 
Tween-20 (American Bioanalytic, Natick, MA, USA) at room temperature for 1 hr. The 
following antibodies were used for protein detection: anti-caspase-3, 585 rabbit 
polyclonal antibody (a kind gift from Dr. Yuri Lazebnik, Cold Spring Harbor 
Laboratories, Cold Spring Harbor, NY, USA), anti-caspase-8 (a kind gift from Dr. 
Andreas Strasser, The Walter and Eliza Hall Institute of Medical Research, Melbourne, 
Australia), anti-caspase-9, clone 5B4 (Stressgen Assay Designs, Ann Arbor, MI, USA), 
anti-flotillin (BD Biosciences), GM-1 HRP (Sigma-Aldrich), anti-paxillin, clone 165 (BD 
Biosciences), anti-FasL MAB5262 (R&D Systems, Minneapolis, MN, USA), anti-β-actin 
(Sigma-Aldrich), anti-mouse IgG HRP, anti-rabbit IgG HRP, and anti-rat IgG HRP (all 
from Jackson Laboratory). Densitometry was performed using Image Studio Lite v5 (LI-
COR Biotechnology, Lincoln, NE, USA). 
bVAD active caspase precipitation 
 Cells were washed once with PBS containing 1% bovine serum albumin (PBS/1% 
BSA) and once with PBS, then incubated on ice for at least 20 min with Lysis Buffer B 
(0.2% Nonidet P-40,150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 10% glycerol, 2 mM 
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sodium orthovanadate, and Complete Protease Inhibitor (Roche Diagnostics)) 
supplemented with 20 μM biotin-VAD-fmk (bVAD) (MP Biomedicals). Protein was 
quantified by Bradford assay (Bio-Rad). 400–600 μg of protein in 300 μL of Lysis Buffer 
B (or 250 μg of protein for lipid raft fractions with no extra buffer added) was pre-cleared 
by rocking over 40 μL of Sepharose 4B beads (Sigma-Aldrich) for 2 hr at 4°C. 
Supernatants were then rocked over streptavidin-Sepharose beads (ThermoFisher 
Scientific) overnight at 4°C. Beads were then washed 3 times with Lysis Buffer B 
without protease inhibitor and boiled for 5 min in Laemmli loading buffer supplemented 
with 2-ME. For precipitations with lipid raft and non-raft fractions, an equal amount of 
protein was used from each fraction for the assay. 
Glutathione Immunoprecipitation 
 Cells were washed once with PBS/1% BSA and once with PBS, then incubated in 
Lysis Buffer B supplemented with 1 mM N-ethylmaleimide (NEM) for at least 20 min on 
ice. Protein was quantified by Bradford assay (Bio-Rad). 300 μg of lysate was brought to 
250 μL with lysis buffer. The reduced control was incubated with 50 mM dithiothreitol 
(+DTT) and rocked at 4°C for 1 hr. The reduced sample was then centrifuged through a 
Micro Bio-Spin P-6 Gel Column (Bio-Rad). For the IgG control, 5 μg of mouse IgG 
(Jackson Laboratory) was added to the sample. For all other samples, 2 μg of anti-
glutathione antibody (Virogen, Watertown, MA, USA) was added. All samples were 
rocked overnight at 4°C. Samples were added to 50 μL of washed Protein G Plus Agarose 
(ThermoFisher Scientific) and rocked at 4°C for 1 hr. Beads were washed and boiled in 
Laemmli buffer before being loaded onto a 15% acrylamide gel. Proteins were separated 
by SDS-PAGE and transferred to a PVDF membrane for immunoblot analysis. 
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Metabolic analyses 
 Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) 
were measured using the Seahorse XFe 96 Analyzer (Agilent Technologies, Santa Clara, 
CA, USA) according to the manufacturer’s specifications. Analysis was performed using 
the Wave Software v2.2.0 or v2.3.0.2 (Agilent Technologies). 
Flow Cytometry 
 For surface staining, cells were washed in PBS and stained with Live/Dead 
Fixable Blue Dead Cell Stain (ThermoFisher Scientific) for 25 min on ice. Cells were 
washed and incubated for 25 min on ice with anti-CD25-BV421 (BioLegend, San Diego, 
CA, USA), anti-CD44-PE (BioLegend), anti CD4-PE-TexasRed (ThermoFisher 
Scientific), anti-CD8-PerCP-Cy5.5 (BioLegend), anti-TCRβ-PE-Cy7 (BioLegend), anti-
CD45RB-FITC (BioLegend). Cells were washed, fixed in 1% (v/v) methanol-free 
formaldehyde, and analyzed on an LSRII (BD Biosciences). 
 For intracellular staining, after staining with Live/Dead Fixable Blue Dead Cell 
Stain and surface antibodies as described above, cells were washed and fixed with 2% 
formaldehyde (v/v) for 15 min on ice. Fixed cells were washed and permeabilized with 
PBS/1% BSA supplemented with 0.03% saponin for 10 min on ice. Cells were washed 
and incubated with anti-cleaved caspase-3 Alexa 647 (Cell Signaling) for 30 min on ice. 
Cells were washed, fixed in 1% formaldehyde (v/v), and analyzed on an LSRII (BD 
Biosciences). 
 All flow cytometry data was analyzed with FlowJo v10 software (FlowJo, 
Ashland, OR, USA). 
Cellular and mitochondrial ROS measurement 
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 Cellular ROS was measured using 2',7'-dichlorodihydrofluorescein 
diacetate (DCFDA) (ThermoFisher Scientific). 5 x 105 cells were incubated with 1 μM 
DCFDA in PBS at 37°C in the dark for 30 min. Cells were washed with cold PBS/1% 
BSA and analyzed immediately by flow cytometry. 
Mitochondrial ROS was quenched using MitoQ (Kelso et al., 2001). Cell cultures were 
incubated with MitoQ or a DMSO control for 4 h. Cells were then stained with DCFDA, 
as described above, for ROS detection. 
 Mitochondrial ROS was measured using the MitoB probe as previously described 
(Cochemé et al., 2011). MitoB specifically targets the mitochondria and is converted to 
MitoP in the presence of ROS. The ratio of MitoP/MitoB was measured using liquid 
chromatography tandem mass spectrometry. 
Complex I activity and mitochondrial extraction 
 Cells were washed with PBS/1% BSA and resuspended in STE buffer (250mM 
sucrose, 5mM Tris, 1mM EGTA, pH 7.4 with HCl). Cells were homogenized and 
centrifuged at 1 000 x g for 3 min at 4°C. The supernatant was then centrifuged at 10 000 
x g for 10 min at 4°C. The supernatant (cytosol) was saved and the pellet (mitochondria) 
was washed with STE buffer. The mitochondria were then resuspended and assayed for 
Complex I activity using the Complex I Enzyme Activity Microplate Kit (MitoSciences, 
Eugene, OR, USA) according to the manufacturer’s specifications. Samples were run in 
parallel with mouse liver mitochondrial extracts as a positive control. Complex I rates 
were calculated by dividing Complex I activity by time. Complex I rates were normalized 
to mouse liver mitochondrial complex I rate. 
Cell Death  
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 Restimulation-Induced Cell Death was induced in day 6 or 7 effector T cells by 
incubation on plate-bound anti-CD3 (10 μg/mL) for 16-18 hr at 37°C. Cells were 
removed and stained with Live/Dead Fixable Blue Dead Cell Stain (ThermoFisher 
Scientific), fixed in 1% formaldehyde (v/v), and analyzed by flow cytometry. 
As a positive control for cell death, day 6 effector T cells were incubated with 400 ng/mL 
FLAG-tagged FasL (Enzo Life Sciences, Farmingdale, NY, USA) and 2 μg/mL anti-
FLAG antibody M-2 (Sigma-Aldrich) for 1.5 hr at 37°C. Cells were then stained with 
Live/Dead Fixable Blue Dead Cell Stain (ThermoFisher Scientific) fixed in 1% 
formaldehyde (v/v), and analyzed by flow cytometry. 
CD4+ T cell subset differentiation 
 Purified CD4+ T cells were activated in complete medium on plate-bound anti-
CD3/soluble anti-CD28 for 2 or 3 days in the presence of differentiating cytokines (Th1: 
4 ng/mL IL-12 (PeproTech, Rocky Hill, NJ, USA) plus 10 μg/mL anti-IL-4 (BioLegend); 
Th2: 10 ng/mL IL-4 (PeproTech) plus 10 μg/mL anti-IFN-γ (BioLegend); Treg: 2 ng/mL 
TGF-β (PeproTech) plus 100 U/mL IL-2). After differentiation, cultures were propagated 
for 2 or 3 days in complete medium containing 50 U/ml IL-2 for Th1 and Th2 cells, and 
100 U/mL IL-2 for Treg. 
Lipid Raft Purification 
 Lipid rafts were separated as previously described (Misra et al., 2007). Briefly, 
cells were lysed on ice for 25 min in TNE buffer (5 mM iodoacetic acid (ThermoFisher 
Scientific), 150 mM NaCl, 10 mM Tris-HCl pH 7.4, 15 mM EDTA, Complete Protease 
Inhibitor) supplemented with 100 mM Na2CO3 and 0.5% Triton X-100. Lysates were 
sonicated and added to 60% Opti-Prep sucrose substitute (Sigma-Aldrich) to make a final 
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concentration of 40% Opti-Prep. Lysates were placed in an ultracentrifuge tube and 
layered over with 30% and 5% solutions of Opti-Prep diluted with TNE buffer. Samples 
were centrifuged for 18 hr at 200 000 x g at 4°C. Eleven 1 mL fractions were taken 
sequentially from each sample. An equal volume of each fraction was used for 
immunoblot analysis. 
Influenza infection of mice 
 Mouse-adapted influenza virus strain A/Puerto Rico/8/1934 H1N1 (PR8) virus 
(Charles River Laboratories, Wilmington, MA, USA) was used to infect mice. Mice were 
briefly anesthetized using 2.3% isoflurane in oxygen and infected intranasally with a 
sublethal dose of PR8 (0.2 LD50) in 0.05 ml of PBS. Control mice received 0.05 ml PBS 
without virus. Mice were monitored daily until harvest on day 6, at which time the 
mediastinal lymph node was harvested from the influenza infected mice, and axillary, 
brachial, and inguinal lymph nodes were extracted from the PBS control mice. 
Lymphocytes were collected and stained for analysis by flow cytometry. 
Statistical Analysis 
 Statistical analyses were performed using the graphing software Prism v7 
(GraphPad Software, La Jolla, CA, USA). The statistical test used for each experiment is 
indicated in the figure legends. The following statistical tests were used: paired and 
unpaired t-test when comparing two conditions (e.g. IL-2 compared to IL-15), one-way 
ANOVA with Tukey test or Dunnett test (when comparing to one control) for correction 
for multiple comparisons when comparing multiple conditions for a single variable (e.g. 
dose titration of 2-DG), two-way ANOVA with Sidak test or Tukey test for correction for 
multiple comparisons when comparing multiple variables across multiple conditions (e.g. 
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IL-2 with and without anti-CD3 compared to IL-15 with and without anti-CD3). All data 
met the assumptions of the statistical tests used and variation between the compared 
groups was similar. 
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2.8 Figure Legends 
Figure 2.1. IL-15 drives increased oxygen consumption, complex I activity, and 
mitochondrial ROS. Anti-CD3/CD28-activated T cells were cultured for 3 days in IL-2 
or IL-15. (A) Oxygen consumption rate (OCR) was measured by extracellular flux 
analysis. O = Oligomycin A (inhibitor of ATP synthase), F = FCCP (uncoupler of the 
electron transport chain), R/A = Rotenone and Antimycin (inhibitors of complexes I and 
III, respectively) (mean ± SD of 4 replicates within the one experiment shown. The graph 
is representative of 2 independent experiments). (B) Complex I activity was measured in 
mitochondrial (Mito) and cytosolic (Cyto) fractions of IL-2- or IL-15-cultured T cells 
(the graph is representative of 2 independent experiments). (C) Complex I rates of 
activity in (B) for mitochondrial fractions, normalized to the rate of activity of complex I 
in mouse liver mitochondria (unpaired t-test; * indicates p<0.05; mean ± SD of data from 
2 independent experiments). (D) Mitochondrial ROS were measured by the conversion of 
mitoboronic acid (MitoB) to mitophenol (MitoP), and the ratio of MitoP/MitoB was 
measured by liquid chromatography tandem mass spectrometry (paired t-test; * indicates 
p<0.05; mean ± SEM of means from 3 independent experiments). 
Figure 2.2. IL-15 induces glutathionylation of caspase-3. Anti-CD3/CD28-activated T 
cells were cultured in IL-2 or IL-15 for 3 days before lysis. (A) Glutathione 
immunoprecipitation (GSH IP) was performed on whole cell lysates (WCL). 
Immunoprecipitations were conducted alongside a reduced control (+DTT) and an IgG 
control (IgG). The WCL and GSH IP were immunoblotted for caspase-3 (the immunoblot 
is representative of 3 independent experiments). (B) Densitometry of cleaved caspase-3 
detected in the IL-2 and IL-15 GSH IP lanes in (A), indicative of glutathionylated 
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cleaved caspase-3 (paired t-test; * indicates p<0.01; mean ± SD; n = 3 independent 
experiments). (C) ROS were measured by flow cytometry using DCFDA in IL-2- or IL-
15-cultured T cells in the presence or absence of 200 nM mitoquinone (MitoQ) for 4 h 
(two-way ANOVA with Sidak’s correction; data indicate a fold change compared to IL-2 
DMSO control; NS = not significant; * indicates p<0.05; mean ± SEM; n = 3 
independent experiments). (D) Caspase activity was measured by DEVD rhodamine 
fluorescence in IL-2- or IL-15-cultured T cells with or without MitoQ (two-way ANOVA 
with Sidak’s correction; NS = not significant; * indicates p<0.05; mean ± SD of 3 
replicates within the one experiment shown. The graph is representative of 2 independent 
experiments). (E) IL-2- or IL-15-cultured T cells were incubated with MitoQ (200 nM) or 
DMSO for 24 h. Restimulation-induced cell death was then promoted by 16 h anti-CD3 
restimulation followed by Live/Dead staining and flow cytometry (two-way ANOVA 
with Tukey’s correction; NS = not significant; mean ± SD of 2 replicates).  
Figure 2.3. Caspase activity parallels glycolysis and CD25 expression in T cells. (A-
C) T cells were activated with anti-CD3/CD28 for 2 days and cultured in IL-2 for a third 
day. T cells were then washed and cultured in IL-2 or IL-15 for an additional 7 days. (A) 
Baseline extracellular acidification rate (ECAR) was measured by extracellular flux 
analysis at days 0, 6, and 10 (two-way ANOVA with Tukey’s correction; NS = not 
significant; * indicates p<0.01; mean ± SEM of means from 3 independent experiments). 
(B) CD25 expression measured daily by flow cytometry (the graph is representative of 2 
independent experiments). (C) Caspase activity was measured daily by DEVD rhodamine 
release (mean ± SD of 3 replicates within the one experiment shown. The graph is 
representative of 2 independent experiments). (D) Anti-CD3/CD28-activated T cells were 
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cultured in IL-2 or IL-15 for 3 days. For a positive control, IL-2-cultured T cells were 
incubated with FasL for 1.5 h to induce caspase-3 activity and cell death. Cells were 
stained for intracellular active caspase-3 and analyzed by flow cytometry (the graph is 
representative of 3 independent experiments). (E, F) Purified CD4+ T cells were 
differentiated into Th1, Th2, and Treg subsets by activation with anti-CD3/CD28 for 2 or 
3 days along with the appropriate cytokines (see Materials and Methods). T cell subsets 
were then cultured for an additional 2 or 3 days in IL-2 according to an established 
protocol (Michalek et al., 2011). (E) Baseline ECAR was measured by extracellular flux 
analysis (one-way ANOVA with Tukey’s correction; ** indicates p<0.0001; mean ± SD 
of 5 replicates within the one experiment shown. The graph is representative of 2 
independent experiments). (F) Caspase activity was measured by DEVD rhodamine 
fluorescence (one-way ANOVA; ** indicates p<0.0001; mean ± SD of 3 replicates 
within one experiment. The graph is representative of 2 independent experiments). 
Figure 2.4. Glycolysis regulates caspase activity in effector T cells. Anti-CD3/CD28-
activated T cells were cultured for 3 days in IL-2 with (A) 2-deoxyglucose (2-DG, 0-5 
mM). Baseline ECAR was measured (one-way ANOVA with Dunnett’s correction; ** 
indicates p<0.001; mean ± SEM of means from 3 independent experiments). (B, C) 
Activated T cells were cultivated for 3 days in (B) IL-2 or (C) IL-15, in medium, 2-
deoxyglucose (2-DG, 5 mM), without glucose (No glucose), Rapamycin (300 nM), or 
DMSO control. Caspase activity was measured by DEVD rhodamine fluorescence. Data 
indicate a fold change compared to the control (one-way ANOVA with Dunnett’s 
correction; * indicates p<0.05; ** indicates p<0.001; mean ± SD; n = 3 independent 
experiments). 
90 
 
Figure 2.5. Activity of caspase-3, but not caspase-8 or -9, is regulated by the 
glycolytic state of effector T cells. Activated T cells were cultured for 3 days in IL-2 
with or without 5 mM 2-DG. (A) Active caspases were selectively precipitated using 
biotin-VAD (bVAD) and streptavidin Sepharose beads, and immunoblotted for caspases-
8, -9, -7, and -3 (the blot is representative of 2 independent experiments). (B) 
Densitometry of active caspase-8, -9, -7, and -3 in (A) (For caspase-8, -9, and -3: two-
way ANOVA with Sidak’s correction; For caspase-7: unpaired t-test; NS = not 
significant; * indicates p<0.05; mean ± SD of 2 replicates). (C) Cell death was 
determined by Live/Dead staining after centrifugation over Histopaque. (unpaired t-test; 
mean ± SD; ** indicates p<0.01; n = 3 independent experiments). (D) Restimulation-
induced cell death was promoted by 16 h anti-CD3 restimulation of IL-2-cultured T cells 
cultured with or without 2-DG, and cell death determined by Live/Dead staining using 
flow cytometry. Data indicate fold change compared to the unstimulated medium control 
(two-way ANOVA with Sidak’s correction; NS = not significant; * indicates p<0.05; 
mean ± SD of 2 replicates; n = 2 independent experiments). (E) Cell lysates of T cells 
grown in the indicated conditions were immunoblotted for FasL. Controls included FasL-
transfected 3T3 cells or mock-transfected 3T3 cells (the immunoblot is representative of 
2 independent experiments). (F) Densitometry of FasL in (E) (one-way ANOVA; * 
indicates p<0.05; ** indicates p<0.01; mean ± SD of 2 replicates). 
Figure 2.6. IL-2-mediated glycolysis promotes the localization and cleavage of 
caspase-3 in lipid rafts. Activated T cells were cultured for 3 days in IL-2 or IL-15. (A, 
B) Cells were sonicated before fractionation in an ultracentrifuge over an Optiprep 
density gradient. Fractions of 1 mL each were collected. A volume of 30 μL of each 
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fraction was used to perform an immunoblot for capsase-3, GM-1 (lipid rafts), and 
paxillin (non-raft) (the blot is representative of 2 independent experiments). (C) 
Densitometry of the ratio of cleaved capsase-3 to pro-caspase-3 in raft and non-raft 
fractions (n = 2 independent experiments). (D) bVAD precipitation of active caspases 
was performed on the indicated raft and non-raft fractions and precipitates were 
immunoblotted for active caspase-3 (the blot is representative of 2 independent 
experiments). (E) Densitometry of active caspase-3 in raft and non-raft fractions (n = 2 
independent experiments). 
Figure 2.7. Caspase-3 is active in vivo in proliferating T cells after influenza 
infection. Mice received influenza virus strain A/Puerto Rico/8/1934 H1N1 virus (FLU) 
or PBS control intranasally and lymph nodes were extracted 6 days after infection. 
Mediastinal lymph node cells (flu-infected mice) or non-mediastinal lymph node cells 
(PBS control mice) were stained and analyzed by flow cytometry. (A) Representative 
contour plots of live CD4+ (left) or CD8+ (right) T cells from PBS control mice (top) or 
flu-infected mice (bottom) for CD44 versus active caspase-3. The two rectangular inserts 
identify the CD44high (upper) and CD44low (lower) populations. All events to the right of 
the vertical line are positive for active caspase-3. Numbers represent the percentage of 
CD44high or CD44low gated cells that are positive for active caspase-3 (%+), and the 
median fluorescent intensity of active caspase-3 (MFI). (B) Graphs of the percent 
positive cells for active caspase-3 (top) and MFI (bottom) (two-way ANOVA with 
Tukey’s correction; mean ± SD; * indicates p<0.001, ** indicates p<0.0001; NS = not 
significant; n = 5 mice per group). 
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Figure 2.1: IL-15 drives increased oxygen consumption, complex I activity, and 
mitochondrial ROS 
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Figure 2.2: IL-15 induces glutathionylation of caspase-3 
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Figure 2.3: Caspase activity parallels glycolysis and CD25 expression in T cells 
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Figure 2.4: Glycolysis regulates caspase activity in effector T cells 
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Figure 2.5: Activity of caspase-3, but not caspase-8 or -9, is regulated by the 
glycolytic state of effector T cells 
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Figure 2.6: IL-2-mediated glycolysis promotes the localization and cleavage of 
caspase-3 in lipid rafts 
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Figure 2.7: Caspase-3 is active in vivo in proliferating T cells after influenza 
infection 
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3.1 Abstract 
 An effective adaptive immune response requires rapid T cell proliferation, 
followed by equally robust cell death. These two processes are coordinately regulated to 
allow sufficient magnitude of response followed by its rapid resolution, while also 
providing the maintenance of T cell memory. Both aspects of this T cell response are 
characterized by profound changes in metabolism; glycolysis drives proliferation whereas 
oxidative phosphorylation supports the survival of memory T cells. While much is known 
about the separate aspects of T cell expansion and contraction, considerably less is 
understood regarding how these processes might be connected. We report a link between 
the induction of glycolysis in CD8+ T cells and upregulation of the inhibitor of complex I 
and oxidative phosphorylation, methylation-controlled J protein (MCJ). MCJ acts 
synergistically with glycolysis to promote caspase-3 activity. Effector CD8+ T cells from 
MCJ-deficient mice manifest reduced glycolysis and considerably less active caspase-3 
compared to wild-type cells. Consistent with these observations, in non-glycolytic CD8+ 
T cells cultured in the presence of IL-15, MCJ expression is repressed by methylation, 
which parallels their reduced active caspase-3 and increased survival compared to 
glycolytic IL-2-cultured T cells. Elevated levels of MCJ are also observed in vivo in the 
highly proliferative and glycolytic subset of CD4-CD8- T cells in Fas-deficient lpr mice. 
This subset also manifests elevated levels of activated caspase-3 and rapid cell death. 
Collectively, these data demonstrate tight linkage of glycolysis, MCJ expression, and 
active caspase-3 that serves to prevent the accumulation and promote the timely death of 
highly proliferative CD8+ T cells. 
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3.2 Introduction 
 The adaptive immune response is characterized by rapid proliferation of 
responding T cells followed by equally rapid cell death. These two processes need to be 
tightly coordinated, lest this result in excessive expansion or loss of T cells. Whereas 
much is known about the metabolic shifts leading to T cell proliferation and the death 
pathways resulting in contraction, less is appreciated about the possible close linkage of 
these two processes. Understanding this connection is critical to the design of T cell 
immunotherapy where enormous expansion of T cells is performed ex vivo using 
exogenous cytokines followed by the need for the cells to survive in vivo when infused in 
patients. 
 T cell activation induces IL-2 and CD25 signaling, promoting IL-2-induced 
glycolysis that is characterized by the activation of mTOR and the upregulation of Glut1 
(Finlay et al., 2012; Ray et al., 2015). The increase in glycolysis allows cells to generate 
the synthetic molecules needed for rapid proliferation and proper effector function. 
Proliferative effector T cells are highly sensitive to various forms of cell death, including 
Fas stimulation and cytokine withdrawal (Alderson et al., 1995; Larsen et al., 2017; Snow 
et al., 2010). The cytokine IL-15 is also important in proliferation. By contrast, IL-15 
reduces glycolysis and promotes oxidative phosphorylation and T cell survival to the 
memory stage, although the mechanism of survival is not clear (Saligrama et al., 2014; 
van der Windt et al., 2012).  
 In addition to the critical role of metabolism in T cell activation and proliferation, 
the metabolic state of T cells may greatly influence their susceptibility to cell death. 
Given that caspases are frequently the mediators of cell death, we considered that 
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metabolism might regulate the activity of certain caspases, and as such, set a level of 
susceptibility to cell death. We have previously observed that IL-2 selectively promotes 
caspase-3 activity whereas IL-15 inhibits its activation. Knowing that IL-15 promotes 
activity of complex I of the electron transport chain and oxidative phosphorylation 
(Secinaro et al., 2018; van der Windt et al., 2012), we considered that other mechanisms 
of reducing glycolysis and enhancing complex I activity might also reduce caspase-3 
activity.  
 Methylation-controlled J protein (MCJ) was recently identified as a negative 
regulator of complex I (Hatle et al., 2013). MCJ is a member of the DNAJ family of 
proteins, encoded by the gene dnajc15 (Hatle et al., 2013; Hatle et al., 2007; Shridhar et 
al., 2001). MCJ is located at the inner mitochondrial membrane and interacts with 
complex I of the electron transport chain (Hatle et al., 2013). This interaction decreases 
complex I activity and reduces supercomplex formation of members of the electron 
transport chain, which results in a decrease in mitochondrial respiration (Champagne et 
al., 2016). MCJ-deficient T cells thus manifest increased complex I activity, 
mitochondrial respiration, and provide more effective memory than wild-type T cells 
(Champagne et al., 2016). We therefore considered that regulation of MCJ expression 
may be a component of the linkage between metabolism and cell death. 
 Here, we observe that as T cells enter glycolysis via IL-2 in vitro to become 
effector T cells they strongly upregulate MCJ. Paralleling this was an increase of caspase-
3 activity. Similar findings were observed in vivo with rapidly proliferating glycolytic 
CD4-CD8- T cells from Fas-deficient lpr mice. By contrast, in MCJ-deficient IL-2 
effector T cells caspase-3 activity was decreased. IL-15-culutured T cells downregulated 
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MCJ expression through its gene methylation, which also paralleled reduced caspase-3 
activity. These findings establish a close relationship between glycolysis, MCJ, and 
mitochondrial respiration, with a level of caspase-3 activity that is independent of Fas 
engagement. 
 
3.3 Results 
3.3.1 Induction of glycolysis by IL-2 increases expression of MCJ and reduced 
complex I activity which is reversed by IL-15 
 We modeled in vitro the metabolic switch that occurs in CD8+ T cells during the 
transition from naïve to effector and then to memory T cells by analyzing freshly purified 
CD8+ T cells before, and at various times after, activation with anti-CD3/CD28. After 
two days, cells were removed from the activation stimuli and cultured for an additional 
day in IL-2, then washed and recultured for an additional three days in cytokines known 
to induce differing metabolic states; IL-2 to induce glycolysis and effector T cells versus 
IL-15 to induce oxidative phosphorylation and memory T cells (van der Windt et al., 
2012). IL-2-cultured activated CD8+ T cells manifested a rapid increase in glycolysis, as 
measured by extracellular acidification rate (ECAR) and a low oxygen consumption rate 
(OCR) on day 6, whereas IL-15-cultured CD8+ T cells had the opposite metabolic profile, 
consistent with oxidative phosphorylation, in agreement with previous reports (van der 
Windt et al., 2012) (Fig. 3.1A). 
 As oxygen consumption is primarily due to mitochondrial activity of the electron 
transport chain, we examined complex I activity in naïve versus IL-2-cultured CD8+ T 
cells. Corresponding to the decrease in OCR as naïve T cells became glycolytic effector 
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T cells with IL-2 stimulation, we observed a decrease in complex I activity in IL-2 CD8+ 
T cells (Fig. 3.1B). We further investigated the possibility that the metabolic switch 
between oxidative phosphorylation and glycolysis reflected changes in methylation-
controlled J protein (MCJ), which physically associates with complex I and inhibits its 
activity (Hatle et al., 2013). MCJ expression in naïve CD8+T cells increased following 
activation with IL-2, peaking at days 3-5. In contrast, MCJ expression decreased rapidly 
in IL-15-cultured CD8+ T cells compared to IL-2, resembling resting naïve CD8+T cells 
(Fig. 3.1C). Of further interest was that paralleling the increase in MCJ expression with 
IL-2, CoxIV (a subunit of complex IV) decreased, reaching low expression levels at days 
3-4, and then increasing toward initial levels. This shows that the increase in MCJ was 
not the result of a global increase in mitochondrial mass, as reflected in the MCJ:CoxIV 
ratio (Fig. 3.1C). IL-15-cultured-CD8+ T cells manifested the opposite profile with 
persistently high CoxIV, compared to their low levels of MCJ (Fig. 3.1C). 
3.3.2 Inhibition of DNA methyltransferases results in the expression of MCJ in IL-
15-cultured CD8+ T cells 
 Given the differences in MCJ expression between glycolytic IL-2-cultured cells 
and non-glycolytic IL-15-cultured cells, we investigated the possibilities that IL-15 
reduces MCJ expression or glycolysis drives MCJ expression. The gene encoding MCJ, 
dnajc15, is known to be regulated by methylation-induced suppression (Shridhar et al., 
2001; Strathdee et al., 2004). To investigate whether the reduction in MCJ by IL-15 was 
related to gene methylation we cultured activated CD8+ T cells in IL-15 with 1 μM 5-
azacytidine (5azaC), a DNA methyltransferase inhibitor, or with an equivalent 
concentration of DMSO as a vehicle control for 2 days starting at day 3. We observed 
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that 5azaC treatment resulted in a substantially increased expression of MCJ protein, and 
this was to a much greater extent than for complex I component NDUFA9, or complex 
IV component CoxIV (Fig. 3.2). This was reflected in the MCJ:NDUFA9 ratio, 
indicating 5azaC treatment did not globally increase mitochondrial proteins (Fig. 3.2). 
3.3.3 Glucose utilization increases MCJ protein expression 
 We directly examined the influence of glycolysis on MCJ expression using 2-
deoxy-D-glucose (2-DG), which inhibits glycolysis after its phosphorylation by 
hexokinase (Wick et al., 1957). We cultured activated CD8+ T cells in IL-2 for 3 days in 
the absence or presence of 5 mM 2-DG, starting at day 3. Cells cultured with IL-2 plus 2-
DG expressed dramatically less MCJ compared to IL-2 alone (Fig. 3.3).  Such decreases 
were not observed for NDUFA9 or CoxIV, as reflected in the MCJ:NDUFA9 ratio (Fig. 
3.3). These data demonstrate a link between MCJ expression and glucose utilization in 
CD8+ T cells. 
3.3.4 Reduced glycolysis and caspase-3 activity of T cells from MCJ-deficient mice.  
 Given the link between glucose utilization and MCJ expression, we measured 
glycolysis in IL-2-cultured effector CD8+ T cells derived from either MCJ-deficient 
(MCJ-/-) mice or wild-type (WT) control mice by extracellular flux analysis at day 4. The 
MCJ-/- T cells were less glycolytic than the WT T cells (Fig. 3.4A). We have previously 
reported that glycolysis drives caspase-3 activity (Secinaro et al., 2018). Since MCJ-/- T 
cells were less glycolytic than WT T cells, we hypothesized the MCJ-/- T cells would 
have reduced caspase-3 activity. Cell lysates were prepared in the presence of biotin-
VAD (bVAD), which labels active caspases, on day 6 (Zhou et al., 2006). Active 
caspases were then precipitated from lysates with avidin-sepharose, and precipitates 
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immunoblotted for caspase-3 and caspase-8. We observed that MCJ-/- CD8+ T cells 
manifested a pronounced decrease in active caspase-3 and a modest increase in active 
caspase-8 (Fig. 3.4B). CD8+ T cells deficient in MCJ have been shown previously to be 
resistant to cell death during a simulated immune contraction phase using cytokine 
withdrawal (Champagne et al., 2016). However, the mechanism for this increased 
survival is not known. Since cell death by either cytokine withdrawal or T cell receptor 
restimulation is mediated by caspases (Snow et al., 2010), we examined whether this 
resistance to cell death extended also to restimulation-induced cell death (RICD). We 
restimulated day 6 effector WT or MCJ-/- T cells with anti-CD3 overnight, and measured 
cell death by LiveDead stain and flow cytometry. This revealed a trend toward a decrease 
in cell death and caspase activity after restimulation in the MCJ-/- T cells compared to 
WT, though the difference did not reach statistical significance (Fig. 3.4C and D). 
3.3.5 Highly proliferative and glycolytic T cells in vivo manifest high levels of MCJ 
and increased active caspase-3 
  To examine whether these observations in vitro extend to proliferative glycolytic 
T cells in vivo, we examined a highly proliferative T cell subset that exists in Fas-
deficient lpr mice. CD4-CD8- (double negative, DN) T cells accumulate in lpr mice with 
age and our previous studies have shown that by in vivo BrdU labeling a remarkable 18% 
of this subset undergoes cell cycling in a 24 h period compared with only about 5-6% of 
the CD4+ and CD8+ (B220-) T cells from the same mice (Fortner et al., 2017). Consistent 
with this, we observed that freshly isolated lpr DN T cells were highly glycolytic, as 
revealed by ECAR, compared to the B220- T cells (Fig. 3.5A). In parallel with their high 
glycolytic state, the DN T cells also expressed high levels of MCJ compared to the B220- 
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T cell subset (Fig. 3.5B). Similar increases in NDUFA9 or CoxIV were not observed in 
the DN population, as reflected in the MCJ:NDUFA9 ratio (Fig. 3.5B). 
 Given the increased glycolysis and MCJ expression in the DN T cells, we 
examined whether there was also an increase in caspase-3 activity. We first measured 
caspase-3 activity by flow cytometry and found a five-fold increase in cells positive for 
active caspase-3 in the DN T cells compared to the B220- T cells (Fig. 3.6A). This was 
confirmed by bVAD precipitation (Fig. 3.6B). This paralleled an almost two-fold 
increase in spontaneous cell death in the DN T cells compared to B220- T cells (Fig. 
3.6C). 
3.4 Discussion 
 The current findings highlight the coordinated regulation between induction of 
glycolysis and the negative regulation of mitochondrial respiration and oxygen 
consumption in the electron transport chain (ETC) in T cells. We show as resting naïve 
CD8+ T cells are activated and increase glycolysis in the presence of IL-2, they decrease 
electron transport and oxygen consumption by reducing expression of the ETC 
complexes. Congruently, expression of the complex I negative regulator methylation-
controlled J protein (MCJ) is increased, further reducing electron transport and oxidative 
phosphorylation (OXPHOS). The presence of MCJ also acts synergistically with 
glycolysis to promote caspase-3 activation. This likely acts as a safeguard to prevent the 
accumulation of highly proliferative CD8+ T cells that might cause damage to self-
tissues. 
 The metabolic switch from OXPHOS in naïve and memory T cells to glycolysis 
in effector T cells is crucial for supporting their rapid proliferation and synthetic capacity. 
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Under such proliferative conditions, it is important to shunt glucose metabolites into 
synthetic pathways, such as the pentose phosphate pathway, rather than the Krebs cycle 
and ATP production by the ETC. It may thus be beneficial in certain instances for 
glycolytic T cells to actively suppress the ETC by reducing expression of its components 
as well as upregulating an inhibitor, MCJ. This notion is consistent with the observation 
that inhibition of glycolysis with 2-DG decreased the MCJ:NDUFA9 ratio. 
 The expansion of proliferative effector T cells is paralleled by an increase in 
caspase-3 activity, which sensitizes them to restimulation-induced cell death. We have 
previously shown that caspase-3 activity is regulated in part by the glycolytic state of the 
cell, and caspase-3 activity is also reduced in the presence of 2-DG (Secinaro et al., 
2018). Activated CD8+ T cells deficient in MCJ manifest increased oxygen consumption 
compared to wild-type cells, and an increased memory response to influenza (Champagne 
et al., 2016). This resembles IL-15-cultured T cells, which also have increased oxygen 
consumption and reduced active caspase-3 compared to IL-2-cultured T cells (Saligrama 
et al., 2014; Secinaro et al., 2018; van der Windt et al., 2012). As both IL-15 and MCJ 
deficiency contribute to increased T cell memory, their common reduction in active 
caspase-3 is likely a significant contributing factor in enhancing their survival. 
 How IL-15 and MCJ-deficiency might inhibit caspase-3 activity is uncertain at 
present, but two possible mechanisms are conceivable. One is that the increased oxygen 
consumption might result in increased reactive oxygen species that could inactivate 
caspase-3 by glutathionylation or nitrosylation of caspase-3 at the critical cysteine in the 
enzymatic pocket (Huang et al., 2008b; Mitchell and Marletta, 2005b). We have observed 
this for IL-15-cultured T cells compared to IL-2-cultured T cells (Saligrama et al., 2014; 
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Secinaro et al., 2018). A second process would be preventing caspase-3 acylation and 
hence migration to lipid rafts and its self-activation. In preliminary studies we have 
observed that IL-2 promotes acylation of caspase-3. 
 The lpr CD4-CD8- (DN) T cells provided a useful in vivo source of rapidly 
proliferating T cells in which to test our in vitro observations. We have previously shown 
using in vivo BrdU labeling of proliferating cells that a remarkable 18% of the DN T cells 
in lpr mice divide within a given 24 h period (Fortner et al., 2017). This extraordinary 
rate of proliferation was paralleled by a high rate of glycolysis as well as elevated levels 
of MCJ. The high levels of caspase-3 activity in lpr DN T cells paralleled their rapid cell 
death ex vivo, which was obviously independent of Fas expression since Fas is absent on 
lpr T cells. This serves to underscore that caspase-3 activity in highly proliferative T cells 
is likely independent of death receptor ligation. This is also consistent with our previous 
observations that whereas caspase-3 activity is higher in IL-2-cultured T cells than IL-15-
cultured T cells, caspase-8 activity is quite similar, or even slightly higher, in IL-15-
cultured T cells (Saligrama et al., 2014). Similarly, in the current studies MCJ-deficient 
IL-2-cultured T cells manifested as much or more active caspase-8 than wild-type IL-2-
cultured T cells, despite MCJ-deficient T cells having greatly reduced active caspase-3. 
Thus, caspase-3 activity in proliferating T cells is independent of active upstream 
caspase-8. 
 The elevated expression of MCJ in glycolytic T cells may serve a variety of 
critical functions. By inhibiting complex I and electron transport, it may reduce ROS 
generation, which could reduce ROS-mediated inactivation of caspase-3 (Saligrama et 
al., 2014; Secinaro et al., 2018) and promote susceptibility to cell death of rapidly 
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proliferating T cells. Increased MCJ could thus help divert carbon fuel sources away from 
mitochondrial respiration and toward anabolic pathways, as is seen in actively 
proliferating IL-2-cultured T cells. 
 The current findings establish a close linkage between active T cell proliferation, 
glucose utilization, and activation of caspase-3. That glycolysis promotes activation of 
selectively caspase-3, whereas oxidative phosphorylation actively inhibits caspase-3 
activity through glutathionylation and S-nitrosylation, underscores the tight regulation of 
caspase-3 activity by the metabolic state of T cells. Such a linkage may represent an 
adaptation to ensure that proliferating glycolytic T cells do not escape regulation that 
might promote tumor progression or an autoimmune diathesis. These observations may 
also be highly relevant to providing optimal numbers of T cells for immunotherapy, such 
as with chimeric antigen receptor (CAR)-T cells. This requires the ex vivo expansion of 
very large numbers of T cells often with IL-2, followed by infusion into patients, where 
there may be negligible amounts of IL-2, which could result in considerable rapid loss of 
T cells (Geyer et al., 2018; Hollyman et al., 2009; Tumaini et al., 2013). However, 
reducing caspase-3 activity through the inhibition of MCJ in the infused T cells might 
considerably augment their survival. 
3.5 Materials and methods 
Mice 
 C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME, USA), MRL/MpJ-
Faslpr/J mice (Jackson Laboratory), MCJ-/- mice (Hatle et al., 2013), were housed in an 
American Association for Accreditation of Laboratory Animal Care (AAALAC)-
approved animal facility at the University of Vermont Larner College of Medicine. 
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Tissues from MCJ-/- and C57BL/6J mice were harvested at 2-6 months of age and tissues 
from MRL/MpJ-Faslpr/J mice were harvested at 4 months of age. Protocols were 
approved by the Institutional Animal Care and Use Committee. 
Cell purification 
 CD8+ T cells were purified by negative selection from mouse lymph nodes 
(axillary, inguinal, brachial, cervical) and spleens as described previously (Saligrama et 
al., 2014). In brief, tissues were homogenized through nylon mesh and Gey’s solution 
was used to lyse red blood cells. Combined splenocytes and lymph node cells were 
incubated for 30 min on ice with the following antibodies: anti-MHC class II 
(M5/114/15/2), anti-B220 (RA3-6B2), anti-CD11b (M1/70), and anti-CD4 (GK1.5). 
Cells were then rocked with goat anti-rat coated magnetic beads (Qiagen, Germantown, 
MD, USA) at a 10:1 bead:cell ratio for 45 min at 4°C. Beads and bound cells were 
removed with a magnet. 
 CD4-CD8- B220+ double negative (DN) and B220- (CD4+ + CD8+) T cells were 
purified from the lymph nodes of MRL/MpJ-Faslpr/J in the same manner with the 
following antibodies: DN T cells; anti-MHC class II (M5/114/15/2), anti-CD11b 
(M1/70), anti-CD4 (GK1.5), anti-CD8 (Tib105), and anti-kappa (187.1). B220- T cells; 
anti-MHC class II (M5/114/15/2), anti-CD11b (M1/70), and anti-B220 (RA3-6B2). Wild-
type lymphocytes were obtained from C57BL/6J mouse lymph nodes. 
Cell culture 
 Naïve CD8+ T cells were cultured in RPMI-1640 (Corning, Manassas, VA, USA), 
supplemented with 25 mM HEPES, 100 U/mL penicillin-streptomycin (ThermoFisher 
Scientific, Waltham, MA, USA), 50 μM 2-mercaptoethanol, 5% bovine calf serum (GE 
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Healthcare HyClone, Logan, UT, USA), 2.5 mg/L glucose, 1 mM pyruvate, 2 mM 
glutamine, and 10 μg/mL folate (RPMI-C), and stimulated on 10 μg/mL plate-bound anti-
CD3 clone 145-2C11 (Bio X Cell, West Lebanon, NH, USA) and soluble anti-CD28 
ascites clone 37-51 (1:1000), supplemented with 50 U/mL IL-2 (Cetus, Emeryville, CA, 
USA) at 37°C and 5% CO2 for 2 days. The activated CD8
+ T cells were then removed 
from stimulation and cultured in RPMI-C and 50 U/mL IL-2 for an additional day. For 
studies comparing IL-2- to IL-15-cultured CD8+ T cells, the cells were then washed 3 
times to remove cytokines and cultured in RPMI-C supplemented with either 50 U/mL 
IL-2 or 20 ng/mL IL-15 (a kind gift from Amgen, Thousand Oaks, CA, USA) for 3 days 
or the number of days indicated. For studies of the inhibition of glycolysis, cells were 
cultured in RPMI-C medium with 50 U/mL IL-2 with or without 5 mM 2-deoxy-D-
glucose (Sigma-Aldrich, St. Louis, MO, USA) for 3 days. For studies inhibiting DNA 
methylation, cells were washed 3 times to remove cytokines and cultured in RPMI-C 
supplemented with 20 ng/mL IL-15 and 1 μM 5-azacytidine (Sigma-Aldrich) or an equal 
concentration of DMSO for 2 days. 
Biotin-VAD precipitation of active caspases 
 Cells were washed once with PBS/1% BSA, washed again with PBS, then lysed 
for 30 min on ice in Lysis Buffer supplemented with 20 μM biotin-VAD-fmk (bVAD) 
(MP Biomedicals, Solon, OH, USA). Protein was quantified by Bradford assay. 400-600 
μg of protein in 300 μL of Lysis Buffer was rocked with 40 μL of Sepharose 4B beads 
(Sigma-Aldrich) at 4°C for 2 hr. The beads were removed and the supernatants were 
rocked with 60 μL streptavidin-Sepharose beads (ThermoFisher Scientific) at 4°C 
overnight. The beads bound with active caspases were washed 3 times with Lysis Buffer 
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without protease inhibitor, then boiled for 5 min in Laemmli loading buffer supplemented 
with 2-ME and analyzed by immunoblot for active caspases as described below. 
Immunoblot assays 
 Cells were washed in PBS containing 1% bovine serum albumin (PBS/1% BSA), 
washed again with PBS, then lysed for 30 min on ice in Lysis Buffer (0.5% Nonidet P-
40, 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM sodium orthovanadate, 10% 
glycerol, and Complete Protease Inhibitor (Roche Diagnostics, Indianapolis, IN, USA)). 
Protein concentration of each lysate was determined by Bradford Assay (Bio-Rad, 
Hercules, CA, USA). Lysates were boiled in Laemmli loading buffer supplemented with 
2-mercaptoethanol (2-ME) for 5 min. Proteins were separated by SDS-PAGE on a 15% 
acrylamide gel and transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-
Rad). Membranes were blocked in 4% milk in Tris-buffered saline with 0.1% Tween-20 
(American Bioanalytic, Natick, MA, USA) at room temperature for 1 hr. The following 
antibodies were used for protein detection: anti-caspase-3, 585 rabbit polyclonal antibody 
(a kind gift from Dr. Yuri Lazebnik, Cold Spring Harbor Laboratories, Cold Spring 
Harbor, NY, USA), anti-caspase-8 (a kind gift from Dr. Andreas Strasser, The Walter and 
Eliza Hall Institute of Medical Research, Melbourne, Australia), anti-MCJ (Hatle et al., 
2007), anti-CoxIV (Cell Signaling, Danvers, MA, USA), anti-NDUFA9 (Abcam, 
Cambridge, UK), anti-β-actin (Sigma-Aldrich), anti-mouse IgG HRP, anti-rabbit IgG 
HRP, and anti-rat IgG HRP (all from Jackson Laboratory). Densitometry was performed 
using ImageQuant v8.1 software (GE Healthcare, Chicago, IL, USA). 
Metabolic analysis 
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 Extracellular acidification rates (ECAR) and oxygen consumption rates (OCR) 
were measured with the Seahorse XFe 96 Analyzer (Agilent Technologies, Santa Clara, 
CA, USA) according to the manufacturer’s specifications. Analysis was performed with 
the Wave Software v2.4 or v2.6 (Agilent Technologies). 
Flow cytometry of active caspase-3 
 Cells were washed in PBS and stained in PBS with Live/Dead Fixable Blue Dead 
Cell Stain (ThermoFisher Scientific) on ice for 25 min. Cells were washed with PBS/1% 
BSA and fixed with 2% formaldehyde (v/v) on ice for 15 min. The fixed cells were then 
washed with PBS/1% BSA and permeabilized with PBS/1% BSA supplemented with 
0.03% saponin (PBS/1% BSA/0.03% saponin) on ice for 10 min. Fixed and 
permeabilized cells were then washed and incubated with anti-cleaved caspase-3 Alexa 
647 (Cell Signaling) in PBS/1% BSA/0.03% saponin on ice for 30 min. Cells were 
washed, fixed in 1% formaldehyde (v/v), and analyzed on an LSRII (BD Biosciences). 
Cell death 
 Restimulation-induced cell death was induced in day 6 wild type (WT) or MCJ-/- 
CD8+ T cells by incubation on plate-bound anti-CD3 (10 μg/mL) for 16-18 hr at 37°C. 
Cells were removed from the plate and stained with Live/Dead Fixable Blue Dead Cell 
Stain (ThermoFisher Scientific), fixed in 1% formaldehyde (v/v), and analyzed by flow 
cytometry. 
Complex I activity measurement 
 Cells were washed twice with PBS then resuspended in PBS and assayed for 
complex I activity using the Complex I Enzyme Activity Microplate Kit (MitoSciences, 
Eugene, OR, USA) according to the manufacturer’s specifications. 40 – 100 μg of protein 
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was used for each sample. Complex I rates were calculated per microgram of protein 
used in the assay. 
Statistical analysis 
 Statistical analyses were performed using the graphing software Prism v7 
(GraphPad Software, La Jolla, CA, USA). The following statistical tests were used: 
paired and unpaired t-test when comparing two conditions (e.g. DMSO compared to 
treatment), one-way ANOVA with Tukey’s test for correction for multiple comparisons 
when comparing multiple conditions (e.g. naïve compared to Day 2 compared to Day 6) 
and two-way ANOVA with Sidak test for correction for multiple comparisons when 
comparing multiple variables across multiple conditions (e.g. wild-type versus MCJ-/- 
with and without anti-CD3 restimulation). All data met the assumptions of the statistical 
tests used and variation among the compared groups was similar. 
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3.9 Figure Legends 
Figure 3.1. MCJ expression is upregulated with the induction of glucose utilization 
in CD8+ T cells. (A-C) CD8+ T cells were activated for 2 days with adherent anti-
CD3/CD28, removed and cultured for a third day in IL-2, then washed and cultured for 3 
additional days in either IL-2 or IL-15. (A) Relative baseline extracellular acidification 
rate (ECAR) and oxygen consumption rate (OCR) of CD8+ T cells, measured by 
extracellular flux analysis at days 0, 2, and 6 (one-way ANOVA with Tukey’s correction; 
mean ± SD; * indicates p<0.05; ** indicates p<0.01; *** indicates p<0.0001; n = 3 
independent experiments). (B) Complex I activity in naïve or day 6 IL-2-cultured CD8+ T 
cells (t-test; mean ± SD; *** indicates p<0.0001; n = 3 independent experiments). (C) 
Immunoblot and densitometry (normalized to actin) for methylation-controlled J (MCJ) 
protein, cytochrome c oxidase subunit IV (CoxIV), and actin in whole cell lysates of IL-
2- or IL-15-cultured CD8+ T cells, day 0 through day 6 (blot and graphs are 
representative of 2 independent experiments). Graph of the MCJ:CoxIV ratio 
(representative of 2 independent experiments). 
Figure 3.2. Inhibition of DNA methylation increases MCJ expression in IL-15-
cultured CD8+ T cells. Anti-CD3/CD28-activated CD8+ T cells were cultured in IL-15 
supplemented with 1 μM 5-azacytidine (5azaC) or an equivalent volume of DMSO for 48 
hours. Whole cell lysates were immunoblotted for MCJ, NDUFA9, CoxIV, and actin. Bar 
graph represents densitometry quantification of MCJ normalized to actin and the 
MCJ:NDUFA9 ratio (t-test; mean ± SD; * indicates p<0.05; MCJ:NDUFA9 ratio p = 
0.1707; n = 3 independent experiments; blot is representative of 3 independent 
experiments). 
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Figure 3.3. Inhibition of glycolysis decreases MCJ expression. Anti-CD3/CD28 
activated CD8+ T cells were cultured in IL-2 ± 5 mM 2-deoxyglucose for 3 days. Whole 
cell lysates were immunoblotted for MCJ, NDUFA9, CoxIV, and actin. Bar graphs 
represent the densitometry quantification of MCJ normalized to actin, and the 
MCJ:NDUFA9 ratio (t-test; mean ± SD; * indicates p<0.05; ** indicates p<0.01; n = 3 
independent experiments; blot is representative of 3 independent experiments). 
Figure 3.4. MCJ deficiency reduces glycolysis and caspase-3 activity CD8+ T cells. 
Day 2 anti-CD3/CD28-activated wild-type (WT) or MCJ-deficient (MCJ-/-) CD8+ T cells 
were cultured in IL-2 for an additional (A) 2 or (B-D) 4 days. (A) ECAR was measured 
by extracellular flux analysis. Bar graph is a summary of 5 samples in one experiment (t-
test; mean ± SD; *** indicates p<0.0001; representative of 2 independent experiments). 
(B) Active caspases were precipitated from WT or MCJ-/- whole cell lysates using biotin-
VAD (bVAD). Whole cell lysates and bVAD precipitates were immunoblotted for 
caspase-8 and caspase-3. Bar graph indicates fold change in active caspase-3 compared to 
WT (t-test; mean ± SD; *** indicates p<0.0001; n = 3 independent experiments). (C-D) 
On day 6 WT or MCJ-/- cells were restimulated overnight ± 10 μg/mL anti-CD3. (C) Cell 
death was measured by Live/Dead staining and flow cytometry (Two-way ANOVA; p = 
0.1263; n = 3 independent experiments). (D) Caspase activity was measured by DEVD-
rhodamine fluorescence (Two-way ANOVA; p = 0.0912; n = 3 independent 
experiments).  
Figure 3.5. MCJ expression is increased in vivo in highly glycolytic CD4-CD8- T cells 
from lpr mice. Freshly isolated CD4-CD8- double negative (DN) T cells or CD4+ + CD8+ 
(B220-) T cells from the same lpr mice were purified from lymph nodes by negative 
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selection. (A) ECAR was measured by extracellular flux analysis. Bar graph is a 
summary of 5 samples in one experiment (t-test; mean ± SD; *** indicates p<0.0001; 
representative of 2 independent experiments). (B) Whole cell lysates were 
immunoblotted for MCJ, NDUFA9, CoxIV, and actin. Bar graphs represent the 
densitometry quantification of MCJ normalized to actin, and the MCJ:NDUFA9 ratio 
(mean ± SD; n = 2 independent experiments). 
Figure 3.6. Cell death and active caspase-3 are increased in CD4-CD8- T cells from 
lpr mice. Freshly isolated CD4-CD8- double negative (DN) T cells or CD4+ + CD8+ 
(B220-) T cells from the same lpr mice were purified from lymph nodes by negative 
selection. (A) Representative contour plot of flow cytogram for active caspase-3. The box 
indicates the gate for active caspase-3 based on isotype control staining. Number inserts 
indicate the percent active caspase-3-positive cells. Bar graph is a summary of 
quantification of percent active caspase-3-positive cells from 3 samples in one 
experiment (t-test; mean ± SD; *** indicates p<0.0001; plots and bar graph are 
representative of 2 independent experiments). (B) bVAD precipitation of active caspases 
from DN T cells, B220- T cells, and wild-type lymphocytes (WT), immunoblotted for 
caspase-3. Graph is of the relative densitometry of active caspase-3. (C) Cell death was 
measured by Live/Dead staining and flow cytometry in DN or B220- T cells after 
overnight incubation at 37°C (t-test; mean ± SD; *** indicates p<0.0001; bar graph 
depicts 3 samples from one experiment and is representative of 2 independent 
experiments). 
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Figure 3.1: MCJ expression is upregulated with the induction of glucose utilization 
in CD8+ T cells. 
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Figure 3.2: Inhibition of DNA methylation increases MCJ expression in IL-15-
cultured CD8+ T cells 
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Figure 3.3: Inhibition of glycolysis decreases MCJ expression 
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Figure 3.4: MCJ deficiency reduces glycolysis and caspase-3 activity CD8+ T cells 
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Figure 3.5: MCJ expression is increased in vivo in highly glycolytic CD4-CD8- T cells 
from lpr mice 
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Figure 3.6: Cell death and active caspase-3 are increased in CD4-CD8- T cells from 
lpr mice 
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CHAPTER 4: DISCUSSION 
 The work presented in this dissertation aimed to answer two questions related to 
the links among T cell metabolism, proliferation, and death: 
1. Does metabolism regulate caspase activity in effector T cells? 
2. Are T cell proliferation and contraction linked? 
The results are summarized in the following section, and the implications of those results 
are discussed in the context of what is currently known. Lastly, some potential future 
studies are presented as the future directions of this dissertation. 
4.1 Summary of Results 
 The work of this dissertation is presented in full in Chapter 2 and Chapter 3. The 
findings describe a novel metabolic regulation of caspase-3 activity by glycolysis in 
proliferating T cells, and thus a metabolic link between T cell proliferation and 
contraction. 
4.1.1 Metabolism regulates caspase activity in effector T cells 
 The findings presented in Chapter 2 describe the metabolic regulation of caspase-
3 activity in proliferating T cells. Glycolysis, which is promoted in proliferating T cells 
cultured in IL-2, drives caspase-3 activity, and inhibition of glycolysis reduces caspase-3 
activity. Caspase-3 clusters in lipid rafts in glycolytic T cells, but not non-glycolytic cells, 
indicating a potential mechanism through which glycolysis drives caspase-3 activity. 
Non-glycolytic T cells cultured in IL-15, which favors oxidative phosphorylation, 
produce mitochondrial ROS that is responsible for decreasing caspase-3 activity through 
glutathionylation of a critical cysteine in the enzymatic pocket. Finally, T cells that 
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proliferate in vivo in response to a flu infection also have increased caspase-3 activity 
compared to non-proliferating T cells. 
4.1.2 T cell proliferation and contraction are linked by metabolism 
 The findings in Chapter 3 describe a connection between proliferation and 
contraction in T cells. T cell contraction is marked by cell death and a transition from 
glycolysis to oxidative phosphorylation in the surviving cells. The results show that as 
glycolysis increases in proliferating T cells, the expression of certain electron transport 
chain (ETC) proteins decreases whereas the expression of the complex I negative 
regulator, methylation-controlled J protein (MCJ), increases. As T cells become memory-
like, through culture in IL-15, glycolysis and MCJ expression decrease, while the ETC 
proteins increase in expression. Inhibition of glucose utilization reduces MCJ expression, 
indicating expression is driven by glucose utilization. T cells deficient in MCJ were 
found to have a decrease in caspase-3 activity as well as a decreased sensitivity to cell 
death. Finally, CD4-CD8- T cells, which are highly proliferative, display elevated levels 
of glycolysis and MCJ expression. 
4.2 Synthesis of Findings and Implications 
 The findings presented in this dissertation help to fill gaps in the overall 
understanding of how T cells integrate signals from the tissue environment, such as the 
cytokine milieu, into changes in metabolism, and how those changes in metabolism 
contribute to the survival or death of the cell. This work has implications not only in 
autoimmune disease, but also in the immune response to cancer or an infection. In 
particular, these findings help explain why stronger T cell activation, such as that 
provided by superantigens like staphylococcal enterotoxin B (SEB), is correlated with 
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faster proliferation and faster contraction (Weber et al., 2000). Faster proliferation would 
need a greater induction of glycolysis and, consequently, result in greater caspase-3 
activation. The way in which T cells integrate an external signal into a change in 
metabolism and how metabolism influences cell fate may be more broadly applicable to 
other cells in the immune system, and even non-immune cells. 
4.2.1 Influence of the tissue cytokine environment on T cell metabolism 
 The cytokine environment is a critical regulator of T cell function. During 
activation and the effector response, IL-2 supports T cell growth and proliferation. This 
support is mediated by the induction of glycolysis, which allows for carbons coming from 
glucose to be used to generate amino acids, nucleotides, energy intermediates such as 
NADPH, and lipids, all of which are needed as the cell grows and produces effector 
molecules. IL-15 plays a role in the maintenance of T cells through homeostatic 
proliferation (Alves et al., 2003). Dysregulation of IL-15 expression can cause 
autoimmune disease, such as rheumatoid arthritis, in which the synovial fluid is rich in 
IL-15 and low in IL-2 (McInnes and Liew, 1998a; Waldmann, 2013). Elevated 
expression of IL-15 could promote excessive homeostatic proliferation and the generation 
of cytotoxic CD8+ T cells that have the potential to induce autoimmune disease (Alves et 
al., 2003; King et al., 2004). Targeting the cytokine environment is one potential method 
to reduce autoimmune disease. For example, anti-IL-15 therapy has been used to treat 
both rheumatoid arthritis and celiac disease (Baslund et al., 2005; Richmond et al., 2018; 
Waldmann, 2013). 
 It is possible that targeting metabolism could be a useful stand-alone treatment or 
combination therapy for autoimmune diseases. IL-15 induces mitochondrial metabolism 
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and oxidative phosphorylation, so reducing those metabolic pathways could reverse the 
survival effect that IL-15 has on T cells. Mitochondrial ROS generation could be targeted 
with antioxidants such as mitoQ, which could increase caspase activity enough to induce 
death in the autoreactive cells. 
 Understanding the relationship between the cytokine environment and T cell 
metabolism can also assist in finding novel ways to activate Tregs. Whereas IL-15 
induces cytotoxic T cell proliferation and survival, Tregs are often inactive or decreased 
in a number in autoimmune diseases, and promoting Treg function in affected tissues is a 
potential treatment (Bluestone et al., 2015; Grant et al., 2015). A recent study identified 
TGF-β as a cytokine that can induce different metabolic states in two Treg subsets; 
inducible Tregs (iTregs, generated in vitro and similar to peripheral Tregs generated from 
naïve CD4+ T cells in vivo) and thymic Tregs (tTregs, generated in the thymus during T 
cell development) (Priyadharshini et al., 2018). Currently, it is thought that tTregs 
recognize self-peptide:MHC complexes and are important for restraining immune cell 
migration to within the lymphatic system. iTregs are thought to promote immune 
suppression during inflammation (Shevach and Thornton, 2014). The study found that 
tTregs undergo mTOR-dependent glycolysis, which is reduced in the presence of TGFβ. 
Conversely, iTregs undergo oxidative phosphorylation due to the presence of TGFβ. 
These data suggest that manipulation of the cytokine environment with TGFβ could 
induce a metabolic switch and promote tolerance-inducing iTregs. 
4.2.2 Mechanisms of metabolic switching 
 Proliferating T cells are known to induce glycolysis through IL-2 signaling while 
naïve and memory T cells induce oxidative phosphorylation, which has been linked to IL-
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15 signaling (van der Windt et al., 2012). Less is known about the mechanism through 
which these cytokines induce the corresponding metabolic state, and how T cells can 
switch between metabolic states as they proceed from a naïve cell to a memory cell. IL-2 
signaling activates mTOR, and since mTOR induces the upregulation of glycolysis, this 
is likely the mechanism through which IL-2 drives glycolysis (Ray et al., 2015). The 
mechanism through which IL-15 drives oxidative phosphorylation is less clear. The 
studies presented here provide one piece of that mechanism. Through the methylation of 
the MCJ gene, IL-15 can increase mitochondrial metabolism and oxidative 
phosphorylation. This can lead to increased carbon flow through the TCA cycle to 
support increased ETC activity, which provides a partial explanation for the observed 
utilization of fatty acids to support oxygen consumption seen in IL-15-cultured T cells 
(O'Sullivan et al., 2014). The regulation of MCJ expression by IL-15 signaling provides 
an example for an understudied method through which metabolism can be regulated in T 
cells. Mitochondrial metabolism can be controlled by changing the expression level of 
ETC regulators. DNA methylation, specifically of genes related to metabolic pathways, is 
another understudied but important avenue of investigation that could be very insightful 
in the context of T cell metabolism. As such, IL-15 may promote regulation of several 
genes through epigenetic programming. 
4.2.3 Linkage of glycolysis, proliferation, and cell death 
 One gap in knowledge this dissertation aimed to address was a mechanistic 
explanation for the high degree of sensitivity to death seen in rapidly proliferating T cells 
(Green et al., 2003; Snow et al., 2010). Glycolysis has now been tied to an increase in 
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caspase-3 activity that is seen in proliferating T cells, which enhances their susceptibility 
to cell death.  
 Glycolysis is a metabolic state common to many proliferating cells, and the 
upregulation of caspase-3 activity may also be common in other cell types. In fact, 
intestinal epithelial cells, which renew every 4-5 days, have been shown to become 
glycolytic as they migrate from the crypt to the tip of the villus (Yang et al., 2016). These 
cells then undergo apoptosis and are replaced by newer cells. This apoptosis coincides 
with an increase in caspase-3 activity (Bullen et al., 2006; Grossmann et al., 1998; 
Gunther et al., 2013). It is possible that glycolysis is directly linked to the caspase-3 
activity seen in these cells. 
 This linkage of glycolysis to proliferation and death may also be relevant in 
cancer cells, which are highly glycolytic (Warburg, 1956). Glycolysis has even been a 
recent target of new cancer therapies (Ganapathy-Kanniappan and Geschwind, 2013; 
Sheng and Tang, 2016). Increased glycolysis could drive caspase-3 activity in cancer 
cells as they proliferate, similar to an effector T cell. Unlike effector T cells however, 
cancer cells survive for long periods of time, something that can be partially attributed to 
ROS generated at the ETC (Sabharwal and Schumacker, 2014). It is possible that these 
ROS induce the inactivation of caspase-3, despite high levels of glycolysis, reducing the 
likelihood that a tumor cell will die from caspase-3-induced apoptosis. The link between 
glycolysis and cell death in cancer cells would be valuable to study and might lead to new 
therapeutic strategies.  
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4.2.4 Posttranslational modifications as a way to regulate caspase activity 
 Caspases are not only important for cell death, but also proliferation, cytokine 
maturation, B cell cycling, and cell maturation and differentiation (Lamkanfi et al., 2007; 
Misra et al., 2007). Caspases are zymogens and their activity is typically controlled 
through the cleavage of the pro-caspase into an active enzyme. The identification of the 
posttranslational regulation of caspase activity has been a significant advance to the 
understanding of caspase biology. Redox-dependent posttranslational modifications such 
as S-nitrosylation and glutathionylation are important modifications for caspases because 
they target the cysteine residues of proteins, such as the active site cysteine on caspases 
(Huang et al., 2008b; Mitchell and Marletta, 2005b). While ROS play a role in inducing 
these modifications in T cells, it is not clear which enzymes are responsible for mediating 
them. Further studies will elucidate the mechanisms of S-nitrosylation and 
glutathionylation in T cells and provide new ways to modulate caspase activity through 
the inhibition or activation of the modifying enzymes.  
4.3 Future Directions 
 The work presented in this dissertation successfully addressed the initial aims of 
the study. While a novel connection between glycolysis, proliferation, and death in T 
cells has been identified, more questions can be asked to better understand this important 
connection. Outlined below are several areas of study that have been opened by this 
work. 
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4.3.1 Metabolic state, in vivo proliferation, and sensitivity to cell death of T cell 
subsets ex vivo 
 The studies in Chapters 2 and 3 are mostly performed in vitro, though it is 
important to determine if these results can be corroborated in vivo. The results from the 
flu infection experiment presented in Chapter 2 show that T cells activated by antigen in 
vivo do display an increase in caspase-3 activity as they proliferate. It would be 
interesting to study the connection between glycolysis, proliferation, and caspase-3 
activity in T cells that are proliferating homeostatically in naïve mice. The T cell subsets 
of interest include γδ T cells, NKT cells, and Tregs, all of which homeostatically 
proliferate more rapidly than most other T cells. 
 Using flow cytometry, it is possible to study this connection in vivo. 
Bromodeoxyuridine (BrdU), which incorporates into DNA during DNA synthesis, can be 
used to measure proliferation of cells in vivo. Glucose uptake would be used as a proxy 
for glycolysis, and can be measured with a fluorescent version of 2-deoxyglucose called 
2-NBDG, which has been used in the past to measure glucose uptake in vivo (Chen et al., 
2013). These probes, combined with anti-active caspase-3, can be used to determine the 
level of caspase-3 activity and glucose uptake of the most proliferative T cell subsets by 
ex vivo flow cytometric analysis. 
4.3.2 Heavy carbon labeling and metabolite tracing 
 Extracellular acidification and oxygen consumption rates are simple readouts for 
complex metabolic processes. Glycolysis contributes carbons to many different anabolic 
pathways in the cell. Oxidative phosphorylation is the culmination of any pathway that 
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might generate NADH. To truly study the metabolism of a cell, more in depth analysis 
than extracellular acidification and oxygen consumption rates are needed. 
 IL-2 and IL-15 induce dramatic changes in T cell metabolism, but the full picture 
of the metabolites used and generated in the cells is still unknown. Using mass 
spectrometry, it is possible to identify hundreds of metabolites present within a cell. The 
next step in the study of the metabolic differences between T cells cultured in IL-2 or IL-
15 is to use a mass spectrometry approach to determine the differences in individual or 
classes of metabolites present. However, this approach returns a snapshot of what was 
present in the cell at the time of the analysis. Using carbon-13 (13C)-labeled reagents, 
such as glutamine or glucose, it is possible to identify the metabolites generated from 
those initial fuel sources. This technique, called heavy isotope labeling or metabolite 
tracing, allows for the identification of the pathways a cell will use to catabolize the 
labeled metabolite, and then see where the cell incorporates those carbons. These 
metabolomic studies are in progress and are summarized in Appendix A. 
4.3.3 Mechanism of caspase-3 association with lipid rafts 
 The identification of caspase-3 in lipid rafts was a reasonable expectation 
considering there was no difference in upstream caspase activity between glycolytic and 
non-glycolytic T cells. In glycolytic cells, proximity-induced autoactivation of caspase-3 
is more likely to occur when the caspase is clustered in a confined region, such as a lipid 
raft in the cellular membrane. This raises the question of how caspase-3 initially gets to 
the membrane. Proteins that lack a transmembrane domain often become associated with 
membranes through a lipid-based posttranslational modification called acylation. 
Acylation includes modifications with many lipids or fatty acids including palmitate, 
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which can be generated by glycolytic cells (Levental et al., 2010; Lunt and Vander 
Heiden, 2011). 
 Preliminary studies indicate that palmitate is a major fatty acid produced by 
glycolytic T cells (Fig. A.7). Future studies could investigate the hypothesis that caspase-
3 is acylated in glycolytic T cells and to a lesser extent in non-glycolytic T cells. 
Acylation of caspase-3 can be detected using a biotin switch technique in which the acyl 
groups on proteins are replaced with a biotin-conjugated compound, and then precipitated 
and probed for caspase-3. Expression levels of enzymes involved in acylation could also 
be measured, along with activity levels. If caspase-3 is acylated in glycolytic T cells, then 
blocking fatty acid production and/or acylation should result in a decrease in caspase-3 
localization to lipid rafts and activation. These studies would provide further insight into 
acylation as a method of regulating caspase activity and would link acylation to the 
metabolic state of T cells. 
4.3.4 Mechanism by which MCJ promotes caspase-3 activity 
 Glycolysis and MCJ expression are both linked to activation of caspase-3. While 
glycolysis is known to lead to the localization of caspase-3 in lipid rafts to induce 
activation, it is not known how MCJ drives caspase-3 activity. It is possible that MCJ acts 
to prevent the S-nitrosylation and glutathionylation of caspase-3 by reducing complex I 
activity and subsequently mitochondrial ROS generation. If this is true, then the MCJ-
deficient cells should have increased mitochondrial ROS as well as S-nitrosylation and/or 
glutathionylation of caspase-3. Reducing mitochondrial ROS with mitoQ could then 
increase caspase activity. It is also possible that the expression of MCJ increases 
glycolysis, which would promote caspase-3 activity through the glycolysis-related 
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mechanisms. In this case, the MCJ-deficient cells should have less active caspase-3 
present in lipid rafts. Discovering the mechanism of MCJ induction of caspase-3 activity 
will provide evidence for another non-caspase-mediated method of caspase activation and 
a better appreciation for the complexity of caspase regulation in T cells. 
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APPENDIX A: METABOLOMICS AND METABOLITE TRACING IN T CELLS 
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A.1 Introduction 
 Immunometabolism is now recognized as an important factor in understanding the 
function of immune cells. As was outlined in Chapter 1, different metabolic pathways are 
important at different points in time during an immune response. This has led to a greater 
desire for more detail of the levels of actual metabolites in immune cells at various points 
in an immune response, and for the kinetics and fate of whether these metabolites go in a 
pathway. Thus, as part of our studies of the metabolism of T cells cultivated in IL-2 
versus IL-15, we conducted metabolomics studies in these two T cell populations. 
 We have shown that IL-2-cultured effector T cells utilize glucose and reduce 
OXPHOS, whereas IL-15-cultured memory-like T cells manifest the opposite metabolic 
profile. We thus aimed to better understand how these two T cell populations utilize fuel 
sources. We initially used mass spectrometry to measure the static differences in 
metabolites produced in IL-2-cultured versus IL-15-cultured T cells. We then performed 
kinetic studies using 13C-glucose or 13C-glutamine labeling to follow the kinetics and path 
of carbons from these two fuel sources. 
A.2 Results and Discussion 
 We measured 184 metabolites by mass spectrometry (Table A.1, Fig. A.1). As IL-
15-cultured cells are smaller than the IL-2-cultured cells (and the mass spectrometry was 
performed on an equivalent number of cells), so we reasoned that any metabolites that 
appeared in a higher amount in the IL-15 cells compared to IL-2, were likely to be 
significant for IL-15-driven metabolism. Two metabolites were identified: L-glutamine 
and D-glucose. For most of the metabolites, the IL-2-cultured CD8+ T cells contained the 
greatest amount of these metabolites. 
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 Given the known higher level of OXPHOS in IL-15-cultured T cells, we 
hypothesized that the high level of glutamine in the IL-15-cultured T cells was a result of 
the need to fuel the TCA cycle with glutamine. However, the high level of glucose in the 
IL-15-cultured T cells was unexpected. This static metabolic picture suggested that IL-15 
T cells either took up glucose but did not use it, hence its accumulation, or that it might 
utilize glucose for pathways other than glycolysis to lactate production (which is low in 
IL-15 T cells). To better track the kinetics and fate of glucose and glutamine carbons we 
used 13C-glucose and 13C-glutamine labeling. We added the 13C-glucose or 13C-glutamine 
to glucose- or glutamine-free media and cultured the cells for 6 and 24 hours (for the IL-
15-cultured CD4+ T cells, only the 6-hour time-point was measurable). Key metabolites 
in the glycolysis pathway and the TCA cycle, as well as some amino acids, were 
measured for the presence of 13C (e.g. M+0 representing no labeled carbons and M+3 
representing 3 labeled carbons), indicating the use of either glucose or glutamine to make 
those metabolites. 
 In the 13C-glutamine tracing experiments, the presence of 13C in the metabolites of 
the TCA cycle indicated that glutamine is used by both IL-2-cultured and IL-15-cultured 
T cells to generate glutamate, and subsequently fuel the TCA cycle (Fig. A.2), which is a 
known use of glutamine in cells. There was a moderate amount of labeling in glutathione 
and aspartate in both cultures (Fig. A.3). The 13C-glucose tracing experiments revealed 
that glucose is catabolized in both the IL-2-cultured cells and the IL-15-cultured cells, 
though lactate was produced almost exclusively by the IL-2-cultured cells (Fig. A.4). 
Glucose was used to generate metabolites of the TCA cycle in each of the cell cultures 
(Fig. A.5), though at a low level. We also found glucose to be used by the IL-2-cultured 
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T cells to generate certain amino acids such as alanine and serine, but not by the IL-15-
cultured T cells. The exception was in cysteine, which was generated from glucose in 
each culture (Fig. A.6). Most striking was that when tracking the labeled carbons from 
13C-glucose they appeared to disappear in the IL-15-cultured T cells before entry into the 
TCA cycle. Thus, if glucose was not being metabolized to lactate or the TCA cycle in IL-
15 T cells, it suggested that the carbons were being diverted to another pathway. Due to 
the targeted measurements that were made, we were unable to determine if these carbons 
entered any pathways that branch off glycolysis, such as the pentose phosphate pathway 
or incorporation into lipids. These will be pursued in future studies. 
 In a separate set of analyses, we were interested in the generation of lipids and 
fatty acids in IL-2-cultured and IL-15-cultured T cells, as IL-15-cultured T cells are 
known to use fatty acids to fuel the TCA cycle, and IL-2-cultured T cells may use fatty 
acids such as palmitate to tether caspase-3 to lipid rafts. We measured fatty acids and 
lipids by mass spectrometry in CD4+ and CD8+ T cells cultured in IL-2 or IL-15. We 
observed that triacylglycerides (TAG) were produced in similar amounts between IL-2-
cultured and IL-15-cultured T cells, with the CD8+ T cells producing the most (Fig. A.7). 
Palmitate (16:0) and linoleate (18:0) were favored among the medium-chain fatty acids, 
with the IL-15-cultured cells favoring linoleate with 2 unsaturated double bonds (18:2) 
(Fig. A.6). Palmitate can be used to modify proteins by acylation, which could be used by 
glycolytic cells to modify caspase-3 for localization in lipid rafts. Diacylglycerides were 
found at a higher level in IL-2-cultured cells compared to IL-15 (Fig. A.8). Of the 
glycerophospholipids, phosphatidylcholine was found at a greater amount in the IL-2-
cultured T cells, while cardiolipin was found at a greater amount in CD8+ T cells, 
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compared to CD4+ (Fig. A.9). IL-15-cultured T cells contained a greater amount of 
sphingomyelin compared to IL-2 (Fig. A.10). Together, these data suggest a preference 
for different lipids between IL-2-cultured T cells and IL-15-cultured T cells. A kinetic 
approach to determine the metabolites used to generate those lipids will enable us to 
better understand the role of lipid metabolism in effector function and survival in T cells. 
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Figure A.1: Heat map of metabolite presences from metabolomics screen 
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Figure A.2: TCA cycle intermediates from 13C-glutamine tracing 
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Figure A.3: Other metabolites detected from 13C-glutamine tracing 
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Figure A.4: Glycolysis intermediates from 13C-glucose tracing 
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Figure A.5: TCA cycle intermediates from 13C-glucose tracing 
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Figure A.6: Other metabolites of interest from 13C-glucose tracing 
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Figure A.7: Triacylglycerides detected in lipidomics screen 
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Figure A.8: Diacylglycerides and MADAGs detected in lipidomics screen 
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Figure A.9: Glycerophospholipids detected in metabolomics screen 
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Figure A.10: Other lipids detected in lipidomics screen 
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Table 1: List of metabolites detected in metabolomics screen 
  MEDIAN VALUES 
p-values 
CD4 
IL2/IL15 
p-values 
CD8 
IL2/IL15 Compound Pathway 
CD4 
IL-2 
CD4 
IL-15 
CD8 
IL-2 
CD8 
IL-15 
L-Alanine Amino acids 7.45E+06 6.69E+06 1.45E+07 5.98E+06 0.072708 0.030676 
L-Arginine Amino acids 2.80E+06 2.66E+06 3.69E+06 2.82E+06 0.407852 0.026131 
L-Asparagine Amino acids 1.99E+06 6.22E+05 2.79E+06 1.32E+06 0.076455 0.042529 
L-Aspartate Amino acids 1.23E+07 5.94E+06 1.56E+07 1.01E+07 0.033673 0.117431 
L-Cysteine Amino acids 3.25E+05 2.20E+05 4.59E+05 2.79E+05 0.305108 0.093564 
L-Glutamate Amino acids 2.93E+07 7.85E+06 6.73E+07 1.22E+07 0.08386 0.021772 
L-Glutamine Amino acids 1.33E+06 2.53E+06 1.52E+06 4.52E+06 0.015861 0.014339 
Glycine Amino acids 8.70E+06 7.56E+06 9.59E+06 7.53E+06 0.089711 0.029004 
L-Histidine Amino acids 2.64E+05 2.96E+05 3.73E+05 3.03E+05 0.430782 0.030591 
L-Isoleucine Amino acids 1.96E+06 1.89E+06 2.84E+06 2.21E+06 0.820098 0.076515 
L-Leucine Amino acids 8.99E+06 1.20E+07 1.84E+07 1.16E+07 0.312082 0.023488 
L-Lysine Amino acids 3.81E+05 4.97E+05 6.88E+05 4.86E+05 0.029648 0.024459 
L-Methionine Amino acids 5.32E+05 9.24E+05 1.01E+06 9.21E+05 0.010751 0.154122 
L-Phenylalanine Amino acids 1.07E+06 1.38E+06 2.16E+06 1.20E+06 0.049946 0.000949 
L-Proline Amino acids 1.05E+08 1.46E+07 2.25E+08 2.27E+07 0.083794 0.023635 
L-Serine Amino acids 5.89E+05 2.93E+05 1.16E+06 4.66E+05 0.015903 0.027317 
L-Threonine Amino acids 6.19E+05 5.86E+05 9.26E+05 5.72E+05 0.534458 0.046158 
L-Tryptophan Amino acids 3.23E+05 4.67E+05 6.94E+05 4.12E+05 0.268589 0.280053 
L-Tyrosine Amino acids 7.43E+05 1.02E+06 1.49E+06 8.94E+05 0.076287 0.060215 
L-Valine Amino acids 1.43E+07 1.00E+07 4.22E+07 1.00E+07 0.331358 0.017063 
L-Cystine Amino acids 2.00E+05 1.67E+05 1.15E+05 1.61E+05 0.552432 0.037842 
Kynurenine Amino acids 1.10E+04 1.27E+04 1.43E+04 9.16E+03 0.702875 0.658727 
ATP Nucleotides 0.00E+00 0.00E+00 2.76E+04 0.00E+00 0.42265 0.018577 
ADP Nucleotides 9.40E+05 3.45E+05 1.37E+06 4.42E+05 0.097317 0.031215 
AMP Nucleotides 1.02E+07 6.63E+06 3.77E+07 7.39E+06 0.282606 0.021778 
GMP Nucleotides 4.43E+05 2.06E+05 1.39E+06 2.69E+05 0.183657 0.003058 
IMP Nucleotides 7.44E+04 0.00E+00 1.05E+05 0.00E+00 0.100605 0.015766 
CMP Nucleotides 2.57E+05 7.07E+04 6.34E+05 1.08E+05 0.118015 0.018407 
Hypoxanthine Nucleotides 1.00E+06 7.91E+05 1.03E+06 6.80E+05 0.174395 0.161528 
Adenine Nucleotides 5.26E+05 3.93E+05 1.30E+06 4.68E+05 0.308113 0.025403 
Xanthine Nucleotides 2.45E+04 0.00E+00 7.05E+04 0.00E+00 0.107928 0.012801 
Guanine Nucleotides 1.29E+05 1.18E+05 2.10E+05 1.01E+05 0.464383 0.044314 
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Allantoate Nucleotides 4.13E+04 2.98E+04 2.04E+04 2.14E+04 0.620706 0.944156 
(S)(+)-Allantoin Nucleotides 1.09E+04 1.56E+04 2.48E+04 1.55E+04 0.460547 0.213469 
5-Hydroxyisourate Nucleotides 5.20E+04 4.28E+04 7.41E+04 1.42E+05 0.396269 0.085156 
5--Phosphoribosyl-N-
formylglycinamide 
Nucleotides 2.44E+04 0.00E+00 3.15E+04 0.00E+00 0.022102 0.083677 
5-Phosphoribosylamine Nucleotides 4.96E+03 0.00E+00 1.59E+04 0.00E+00 0.244222 0.058107 
UMP Nucleotides 4.30E+05 2.24E+05 1.47E+06 2.61E+05 0.219222 0.016368 
Cytidine Nucleotides 4.19E+04 3.36E+04 1.65E+05 9.57E+03 0.505794 0.062492 
2--3--Cyclic CMP Nucleotides 0.00E+00 9.87E+03 0.00E+00 1.59E+04 0.072785 0.264603 
3-Ureidopropionate Nucleotides 1.99E+06 6.22E+05 2.79E+06 1.32E+06 0.076455 0.042529 
5-6-Dihydrothymine Nucleotides 7.91E+05 7.94E+05 1.20E+06 7.31E+05 0.710849 0.002913 
Thymine Nucleotides 1.16E+05 9.48E+04 9.78E+04 8.36E+04 0.052002 0.18994 
Thymidine Nucleotides 1.47E+04 7.15E+03 8.13E+03 7.59E+03 0.161941 0.799713 
NAD+ Nucleotides 2.66E+05 7.21E+04 5.35E+05 6.54E+04 0.052271 0.011496 
NADH Nucleotides 5.31E+04 0.00E+00 1.29E+05 8.96E+03 0.135876 0.008261 
NADP+ Nucleotides 1.61E+06 1.44E+06 1.14E+06 1.64E+06 0.838282 0.163485 
NADPH Nucleotides 2.50E+05 2.52E+05 1.79E+05 2.59E+05 0.979524 0.076451 
Pyridoxal Nucleotides 1.44E+05 1.47E+05 1.06E+05 1.24E+05 0.361404 0.176493 
4-Pyridoxate Nucleotides 2.53E+04 6.03E+03 2.10E+04 4.61E+03 0.028138 0.028277 
Pyridoxamine phosphate Nucleotides 0.00E+00 0.00E+00 2.39E+04 2.66E+04 0.42265 0.627359 
Nicotinamide Nucleotides 2.81E+06 1.92E+06 4.83E+06 2.76E+06 0.141886 0.014861 
ADP-D-ribose Nucleotides 6.09E+03 4.02E+03 2.89E+04 1.21E+04 0.011553 0.292165 
Flavin Nucleotides 8.68E+05 5.70E+05 5.12E+05 5.10E+05 0.003935 0.164477 
Adenosine Nucleotides 1.73E+05 6.98E+04 1.63E+05 1.05E+05 0.117165 0.336763 
Guanosine Nucleotides 4.03E+05 6.47E+05 4.59E+05 5.76E+05 0.054387 0.027987 
Inosine Nucleotides 7.50E+04 3.46E+04 1.01E+05 7.67E+04 0.161178 0.320498 
D-Glucose Glycolysis 1.93E+05 4.57E+05 1.12E+05 2.50E+05 0.01678 0.203444 
D-Hexose 6-phosphate Glycolysis 1.59E+06 1.34E+06 1.87E+06 6.43E+05 0.219015 0.09549 
D-Glyceraldehyde 3-
phosphate 
Glycolysis 4.43E+05 1.51E+05 9.01E+05 1.86E+05 0.08294 0.011906 
2-3-Bisphosphoglycerate Glycolysis 1.77E+04 1.43E+04 1.60E+04 1.11E+04 0.558055 0.589865 
2/3-Phospho-D-glycerate Glycolysis 5.07E+05 1.38E+05 7.75E+05 2.35E+05 0.02117 0.042108 
Phosphoenolpyruvate Glycolysis 3.42E+04 5.42E+03 4.30E+04 1.52E+04 0.057914 0.021401 
Pyruvate Glycolysis 3.74E+06 3.33E+06 3.90E+06 2.90E+06 0.167724 0.009775 
Lactate Glycolysis 1.47E+07 7.11E+06 1.52E+07 6.24E+06 0.098765 0.015363 
cis-Aconitate Carboxylic acid 2.94E+05 3.96E+04 5.09E+05 1.05E+05 0.137392 0.013973 
Citrate Carboxylic acid 8.14E+06 1.13E+06 1.37E+07 2.49E+06 0.058377 0.00301 
2-Oxoglutarate Carboxylic acid 4.69E+05 2.14E+05 1.81E+06 1.99E+05 0.064485 0.015398 
2-Oxoglutaramate Carboxylic acid 6.92E+05 7.12E+05 7.41E+05 7.32E+05 0.883276 0.631274 
Succinate Carboxylic acid 9.82E+05 5.84E+05 2.32E+06 5.92E+05 0.187048 0.031421 
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Fumarate Carboxylic acid 1.86E+06 3.12E+05 4.27E+06 5.13E+05 0.056742 0.000454 
Oxaloacetate Carboxylic acid 9.10E+05 7.83E+05 8.90E+05 9.94E+05 0.125545 0.291215 
5-Aminolevulinate Carboxylic acid 4.00E+05 1.94E+05 5.26E+05 1.78E+05 0.130164 0.011687 
D-Glucono-1-5-lactone 6-
phosphate 
Pentose Phosphate 
Pathway 
3.26E+04 3.79E+04 3.79E+04 3.33E+04 0.461316 0.32376 
6-Phospho-D-gluconate 
Pentose Phosphate 
Pathway 
2.06E+04 1.98E+04 3.30E+04 1.54E+04 0.673939 0.073221 
D-Erythrose 4-phosphate 
Pentose Phosphate 
Pathway 
1.25E+05 1.28E+05 1.24E+05 1.33E+05 0.222303 0.289537 
Sedoheptulose 1-
phosphate 
Pentose Phosphate 
Pathway 
2.16E+05 2.59E+06 3.19E+05 9.47E+04 0.085882 0.014742 
alpha-D-Ribose 1-
phosphate 
Pentose Phosphate 
Pathway 
9.70E+05 2.80E+05 8.98E+05 3.79E+05 0.007873 6.36E-05 
Glutathione GSH homeostasis 3.27E+07 1.62E+07 5.34E+07 1.84E+07 0.091319 0.01837 
Glutathione disulfide GSH homeostasis 0.00E+00 1.24E+04 0.00E+00 0.00E+00 0.132214 #DIV/0! 
5-Oxoproline GSH homeostasis 8.53E+06 4.70E+06 1.50E+07 5.60E+06 0.131362 0.044157 
gamma-L-Glutamyl-L-
cysteine 
GSH homeostasis 1.55E+04 6.51E+04 3.11E+04 1.46E+04 0.003797 0.401075 
Dehydroascorbate GSH homeostasis 9.09E+04 1.04E+04 1.91E+05 7.96E+03 0.056599 0.033917 
Ascorbate GSH homeostasis 8.22E+05 8.01E+05 8.09E+05 8.00E+05 0.746642 0.450265 
S-Adenosyl-L-
homocysteine 
Serine biosynthesis 
and one-carbon 
metabolism 
2.50E+04 0.00E+00 7.69E+04 0.00E+00 0.14869 0.039012 
S-Adenosyl-L-methionine 
Serine biosynthesis 
and one-carbon 
metabolism 
8.58E+04 6.60E+03 2.14E+05 6.07E+03 0.066429 0.009586 
L-Homoserine 
Serine biosynthesis 
and one-carbon 
metabolism 
6.19E+05 5.86E+05 9.26E+05 5.72E+05 0.534458 0.046158 
L-Homocysteine 
Serine biosynthesis 
and one-carbon 
metabolism 
1.28E+05 5.67E+04 2.64E+05 2.88E+04 0.009206 0.01371 
D-O-Phosphoserine 
Serine biosynthesis 
and one-carbon 
metabolism 
1.09E+05 4.26E+04 3.39E+05 2.44E+04 0.186883 0.050689 
3-Phosphonopyruvate 
Serine biosynthesis 
and one-carbon 
metabolism 
1.17E+05 1.43E+05 1.31E+05 1.43E+05 0.017432 0.25162 
Cystathionine 
Serine biosynthesis 
and one-carbon 
metabolism 
3.62E+03 0.00E+00 3.24E+03 0.00E+00 0.987044 0.598163 
N-N-Dimethylglycine 
Serine biosynthesis 
and one-carbon 
metabolism 
8.86E+05 8.08E+05 6.49E+05 6.15E+05 0.161273 0.345234 
5,10-
Methenyltetrahydrofolate 
Serine biosynthesis 
and one-carbon 
metabolism 
0.00E+00 0.00E+00 8.72E+04 1.54E+04 0.42265 0.002364 
Ornithine 
urea cycle and 
polyamines 
1.28E+05 6.14E+04 8.44E+04 4.77E+04 0.779059 0.064859 
L-Citrulline 
urea cycle and 
polyamines 
4.51E+04 3.79E+04 2.88E+04 3.06E+04 0.742251 0.658611 
N-(L-Arginino)succinate 
urea cycle and 
polyamines 
2.91E+04 0.00E+00 1.25E+05 0.00E+00 0.134058 0.020551 
Urate 
urea cycle and 
polyamines 
6.98E+04 1.53E+04 2.11E+05 7.75E+03 0.297307 0.0712 
Spermidine 
urea cycle and 
polyamines 
1.73E+06 6.20E+05 2.54E+06 1.05E+06 0.00361 0.099784 
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Spermine 
urea cycle and 
polyamines 
2.86E+05 1.35E+05 4.59E+05 3.06E+05 0.076123 0.491903 
Putrescine 
urea cycle and 
polyamines 
8.72E+05 3.32E+05 1.41E+06 4.60E+05 0.078532 0.018562 
Atherospermidine 
urea cycle and 
polyamines 
0.00E+00 0.00E+00 0.00E+00 1.05E+04 0.42265 0.491965 
N-Acetylneuraminate Aminosugars 0.00E+00 0.00E+00 9.06E+04 0.00E+00 #DIV/0! 0.007919 
CMP-N-
acetylneuraminate 
Aminosugars 3.53E+04 0.00E+00 2.46E+05 0.00E+00 0.188045 0.00126 
N-Glycoloyl-neuraminate Aminosugars 3.44E+04 0.00E+00 3.82E+04 1.92E+04 0.00204 0.065713 
alpha-D-Glucosamine 1-
phosphate 
Aminosugars 2.07E+04 4.39E+03 6.04E+04 0.00E+00 0.04835 0.040595 
D-Glucosamine Aminosugars 2.70E+04 2.66E+04 2.77E+04 2.18E+04 0.139908 0.213033 
L-Arabinose Aminosugars 2.67E+05 2.70E+05 2.56E+05 2.54E+05 0.917799 0.136842 
beta-L-Arabinose 1-
phosphate 
Aminosugars 9.70E+05 2.80E+05 8.98E+05 3.79E+05 0.007873 6.36E-05 
gamma-Glutamyl-gamma-
aminobutyrate 
Arginine and proline 
metabolism 
1.79E+04 1.20E+04 1.74E+04 8.83E+03 0.907852 0.179614 
N-Succinyl-L-glutamate 
Arginine and proline 
metabolism 
6.98E+04 6.75E+04 7.07E+04 5.40E+04 0.974661 0.2359 
N-Succinyl-L-glutamate 5-
semialdehyde 
Arginine and proline 
metabolism 
1.45E+04 1.96E+04 7.41E+04 4.77E+04 0.95637 0.014488 
Phosphocreatine 
Arginine and proline 
metabolism 
1.31E+06 1.36E+06 2.82E+06 1.54E+06 0.800275 0.064045 
Creatine 
Arginine and proline 
metabolism 
1.34E+07 9.68E+06 1.25E+07 5.81E+06 0.340564 0.066637 
Creatinine 
Arginine and proline 
metabolism 
4.18E+05 4.55E+05 5.47E+05 3.90E+05 0.217779 0.003205 
4-Acetamidobutanoate 
Arginine and proline 
metabolism 
4.60E+05 4.54E+05 4.53E+05 4.61E+05 0.517909 0.87405 
N-Acetylornithine 
Arginine and proline 
metabolism 
1.62E+05 1.85E+05 1.66E+05 1.71E+05 0.002336 0.750584 
N-Succinyl-L-citrulline 
Arginine and proline 
metabolism 
0.00E+00 3.56E+03 0.00E+00 7.03E+03 0.313867 0.750099 
Guanidinoacetate 
Arginine and proline 
metabolism 
2.80E+05 6.95E+04 6.33E+05 6.46E+04 0.076905 0.006675 
trans-4-Hydroxy-L-proline 
Arginine and proline 
metabolism 
5.79E+06 1.29E+06 9.90E+06 2.58E+06 0.081736 0.013079 
5-Aminopentanoate 
Arginine and proline 
metabolism 
1.43E+07 1.00E+07 4.22E+07 1.00E+07 0.331358 0.017063 
L-1-Pyrroline-3-hydroxy-
5-carboxylate 
Arginine and proline 
metabolism 
5.98E+05 7.62E+05 1.39E+06 8.30E+05 0.23695 0.010578 
Aminofructose 6-
phosphate 
Arginine and proline 
metabolism 
1.34E+04 3.81E+04 7.29E+04 3.03E+04 0.719887 0.015928 
L-Allothreonine Inositol 6.19E+05 5.86E+05 9.26E+05 5.72E+05 0.534458 0.046158 
Ectoine Inositol 3.39E+05 2.90E+05 2.68E+05 2.44E+05 0.024611 0.219024 
Uracil 
Panthothenate 
metabolism 
5.68E+04 4.95E+04 1.10E+05 5.85E+04 0.415628 0.131984 
5-6-Dihydrouracil 
Panthothenate 
metabolism 
5.98E+05 5.63E+05 5.12E+05 4.66E+05 0.146306 0.19649 
Pantetheine 
Panthothenate 
metabolism 
6.59E+03 3.29E+03 5.41E+03 7.40E+03 0.05854 0.779965 
L-Carnitine Carnitines 2.78E+06 2.72E+06 3.47E+06 2.12E+06 0.935771 0.024973 
Propanoylcarnitine Carnitines 1.05E+06 5.97E+05 5.36E+05 3.02E+05 0.171996 0.047566 
Butanoylcarnitine Carnitines 3.00E+05 8.00E+04 4.97E+05 1.12E+05 0.142359 0.031754 
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Catechol 
Stimulating/Exogenous 
compounds 
4.17E+04 3.78E+04 3.46E+04 4.62E+04 0.969784 0.393787 
Catecholamine 
Stimulating/Exogenous 
compounds 
5.45E+04 6.17E+04 6.11E+04 5.59E+04 0.077114 0.398904 
Serotonin 
Stimulating/Exogenous 
compounds 
6.40E+04 9.97E+04 0.00E+00 3.08E+04 0.612467 0.115503 
Catechin 
Stimulating/Exogenous 
compounds 
8.36E+03 0.00E+00 9.78E+03 7.68E+03 0.010999 0.9923 
Taurine 
Stimulating/Exogenous 
compounds 
1.62E+07 2.03E+07 2.26E+07 1.80E+07 0.110122 0.195495 
Hypotaurine 
Stimulating/Exogenous 
compounds 
6.51E+05 3.26E+05 8.12E+05 3.52E+05 0.156431 0.029762 
sn-Glycerol 3-phosphate 
Glycerophospholipid 
biosynthesis 
2.11E+05 5.09E+04 3.19E+05 5.45E+04 0.019641 0.006811 
Ethanolamine phosphate 
Glycerophospholipid 
biosynthesis 
0.00E+00 9.27E+04 0.00E+00 1.36E+05 0.06536 0.032273 
N-Methylethanolamine 
phosphate 
Glycerophospholipid 
biosynthesis 
5.72E+05 5.39E+05 6.60E+05 5.46E+05 0.188516 0.202876 
sn-glycero-3-
Phosphoethanolamine 
Glycerophospholipid 
biosynthesis 
4.81E+05 3.71E+05 8.26E+04 2.75E+05 0.701032 0.060936 
Diacylglycerylhomoserine 
Glycerophospholipid 
biosynthesis 
3.06E+04 4.67E+04 2.48E+04 1.65E+04 0.592031 0.720078 
CDP-choline 
Glycerophospholipid 
biosynthesis 
0.00E+00 0.00E+00 1.61E+04 0.00E+00 0.42265 0.043266 
Butanoic acid Saturated Fatty acids 1.22E+05 1.77E+05 1.26E+05 1.14E+05 0.264483 0.949846 
Pentanoate Saturated Fatty acids 1.55E+06 5.96E+04 1.08E+06 1.59E+06 0.50837 0.257631 
Hexanoic acid Saturated Fatty acids 1.02E+05 1.20E+05 9.54E+04 1.07E+05 0.177557 0.747281 
Octanoic acid Saturated Fatty acids 1.39E+04 4.06E+04 2.20E+04 1.91E+04 0.185764 0.895049 
Octadecatrienoic acid 
Poly-unsaturated Fatty 
Acids 
2.90E+04 3.55E+04 2.08E+04 2.88E+04 0.353093 0.670345 
Docosahexaenoic acid 
Poly-unsaturated Fatty 
Acids 
5.36E+04 1.27E+05 6.19E+04 4.45E+04 0.00266 0.804765 
alhpa-
tocopheronolactone 
Lipids 1.42E+05 1.29E+05 9.73E+04 1.13E+05 0.899956 0.822927 
hydroxy-dodecanedioic 
acid 
Lipids 5.55E+04 2.54E+04 2.20E+04 1.66E+04 0.10714 0.628056 
Indole Other 6.60E+04 6.03E+04 6.03E+04 5.40E+04 0.583955 0.040829 
Acetyl phosphate Other 8.38E+04 1.41E+05 1.20E+05 9.99E+04 0.073213 0.186379 
Triacanthine Other 7.28E+06 2.93E+06 7.21E+06 1.98E+06 0.168637 0.024111 
1-Hydroxy-2-
aminoethylphosphonate 
Other 1.27E+04 1.69E+05 5.44E+03 2.37E+05 0.022415 0.002269 
N5-Methyl-L-glutamine Other 6.39E+04 6.99E+04 5.77E+04 6.16E+04 0.772619 0.595913 
2-Methyleneglutarate Other 2.65E+04 1.76E+04 5.43E+04 2.85E+04 0.572722 0.03195 
6-
Pyruvoyltetrahydropterin 
Other 0.00E+00 0.00E+00 5.50E+03 0.00E+00 0.42265 0.038041 
6-Lactoyl-5-6-7-8-
tetrahydropterin 
Other 1.39E+06 2.15E+06 1.74E+06 1.83E+06 0.054295 0.392468 
6-Aminohexanoate Other 8.99E+06 1.20E+07 1.84E+07 1.16E+07 0.312082 0.023488 
Leucocyanidin Other 5.37E+04 6.39E+04 6.81E+04 2.62E+04 0.867122 0.139762 
Methylenediurea Other 1.17E+05 8.37E+04 1.23E+05 4.83E+04 0.284546 0.117682 
beta-Butoxyethyl 
nicotinate 
Other 8.28E+04 1.19E+05 1.32E+05 9.54E+04 0.126536 0.324006 
3-Oxalomalate Other 6.46E+04 7.39E+04 6.95E+04 1.55E+05 0.087566 0.067878 
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Cys-Gly Other 2.91E+05 1.53E+05 5.14E+05 1.67E+05 0.106137 0.022454 
2-Deoxy-alpha-D-
glucoside 
Other 2.40E+06 7.26E+05 3.26E+06 9.40E+05 0.064777 0.014643 
cis-p-Coumarate Other 9.97E+04 1.46E+05 2.42E+05 1.17E+05 0.072714 0.004236 
L-Methionine S-oxide Other 3.32E+03 1.43E+04 3.57E+04 3.92E+04 0.027192 0.101541 
N-Acyl-D-
mannosaminolactone 
Other 9.38E+04 1.13E+05 4.62E+04 4.20E+04 0.846898 0.24813 
N6-Methyl-L-lysine Other 1.16E+05 1.54E+05 2.10E+05 2.44E+05 0.173233 0.862469 
Muramic acid Other 1.84E+05 8.72E+04 2.60E+05 7.72E+04 0.095256 0.076655 
Dethiobiotin Other 2.34E+05 1.18E+05 4.81E+05 1.07E+05 0.024221 0.01212 
L-2-Aminoadipate Other 3.75E+05 1.94E+05 2.59E+05 1.83E+05 0.054784 0.170825 
Threonate Other 4.31E+04 7.98E+04 5.07E+04 2.85E+04 0.054181 0.216125 
Tripeptide Other 1.51E+06 3.47E+05 1.05E+06 2.43E+05 0.006907 0.013881 
Maleamate Other 5.30E+05 2.81E+05 8.21E+05 4.93E+05 0.027707 0.101479 
gamma-Glutamyl-Se-
methylselenocysteine 
Other 1.83E+04 4.13E+05 7.92E+04 1.80E+04 0.109108 0.040747 
Diallyl sulfide Other 1.50E+05 5.64E+04 1.65E+05 6.24E+04 0.064123 0.012485 
Shikimate 3-phosphate Other 5.49E+03 0.00E+00 3.67E+04 0.00E+00 0.813192 0.007178 
D-glucono-1,5-lactone Other 1.28E+05 1.53E+05 9.30E+04 9.80E+04 0.437909 0.994762 
2-Dehydro-3-deoxy-D-
glucarate 
Other 3.55E+04 1.81E+03 7.89E+04 5.77E+03 0.057428 0.001181 
Sodium glucuronate Other 3.76E+03 0.00E+00 1.11E+04 0.00E+00 0.138957 0.03339 
Poly-gamma-D-glutamate Other 5.98E+05 7.62E+05 1.39E+06 8.30E+05 0.23695 0.010578 
Dihydroflavonol Other 1.05E+04 0.00E+00 4.25E+04 0.00E+00 0.045372 0.04956 
 
